University of New Mexico

UNM Digital Repository
Biomedical Sciences ETDs

Electronic Theses and Dissertations

12-1-2013

Gene-environment interactions affect long-term
depression (LTD) through changes in dopamine
D2 receptor affinity in Snap25 haplodeficient mice
Michael Baca

Follow this and additional works at: https://digitalrepository.unm.edu/biom_etds
Recommended Citation
Baca, Michael. "Gene-environment interactions affect long-term depression (LTD) through changes in dopamine D2 receptor affinity
in Snap25 haplodeficient mice." (2013). https://digitalrepository.unm.edu/biom_etds/111

This Dissertation is brought to you for free and open access by the Electronic Theses and Dissertations at UNM Digital Repository. It has been
accepted for inclusion in Biomedical Sciences ETDs by an authorized administrator of UNM Digital Repository. For more information, please contact
disc@unm.edu.

Michael J. Baca
Candidate

Biomedical Sciences
Department

This dissertation is approved, and it is acceptable in quality and form for publication:
Approved by the Dissertation Committee:

Dr. L. Donald Partridge

, Chairperson

Dr. Michael C. Wilson

Dr. Andrea Allan

Dr. Conrad James

i

Gene-environment interactions affect long-term
depression (LTD) through changes in dopamine
D2 receptor affinity in Snap25 haplodeficient
mice

by

MICHAEL J. BACA

DISSERTATION
Submitted in Partial Fulfillment of the
Requirements for the Degree of
Doctor of Philosophy
Biomedical Sciences
The University of New Mexico
Albuquerque, New Mexico

December, 2013

ii

Dedication
I would like to dedicate this dissertation to my parents, John and Emily Baca, for
instilling in me the lifelong desire for learning and the value of education. I would also
like to also dedicate this to my uncle, Dr. Mario L. M. Baca, who is an inspiration
through his continued dedication to education up to and including his retirement despite
his lifelong battle with multiple sclerosis.

iii

Acknowledgments
I would like to acknowledge my advisor Dr. Don Partridge, for giving me the
opportunity to work within his lab, for teaching me the basic techniques and
fundamentals involved in electrophysiology, and for all of his tireless support in
developing, performing and presenting the hypothesis and results of this research. I
would also like to acknowledge two of my advisors on my committee, Dr. Michael
Wilson and Dr. Andrea Allan, both for allowing me to work within their labs and for their
steadfast guidance in performance of this research. Dr. Michael Wilson was instrumental
both in permitting the use of Snap25 haplodeficient mutant colonies necessary for this
research, and for his invaluable critiques throughout the research and encouragement to
go beyond my engineering mindset to write and think more like a scientist. Dr. Andrea
Allan was invaluable in developing and understanding how to perform the binding assays
as well as how to perform and interpret statistical analysis of the results.
I would also like to acknowledge another of my advisors, Dr. Conrad James for
opening up opportunities within Sandia National Laboratories which permitted me tie this
research to ongoing Sandia related bioscience projects, and for his constant support
throughout this process. I would also like to thank Sandia National Laboratories itself for
providing the opportunity to pursue this research. I would also like to thank Dr. Dan
Savage and Dr. Martina Rosenberg for helpful guidance in developing and the use of
their lab for the [35S]-GTP-γ-S binding assay. I would also thank Amy Lucero for
managing the mouse colonies including the administration of nicotine and genotyping.
Additional thanks go to a couple of my lab mates, Chessa Scullin and Adrian
Schiess. They both provided invaluable help in learning electrophysiological techniques
and critiques of this research. Acknowledgement for participation in the ongoing research
presented in Appendix 2 includes Adrian Schiess, Dr. Conrad James, Devin Jelinek, and
Dr. Don Partridge.
Finally, last but not least I would like to thank my family for their continual
support and patience through out this process, including my wife Linda, and my children
Samuel, Abigail and Jacob.

iv

Gene-environment interactions affect long-term depression
(LTD) through changes in dopamine D2 receptor affinity in
Snap25 haplodeficient mice

by

Michael J. Baca

B.S. Electrical Engineering, University of New Mexico, 1987
M.S. Electrical Engineering, New Mexico State University, 1989
PhD, Biomedical Sciences, University of New Mexico, 2013

Abstract
Genes and environmental conditions interact in the development of cognitive
capacities and each plays an important role in neuropsychiatric disorders such as attention
deficit/hyperactivity disorder (ADHD) and schizophrenia. Multiple studies have
indicated that the gene for the SNARE protein, SNAP-25 is a candidate susceptibility
gene for ADHD, as well as schizophrenia, while maternal smoking is a candidate
environmental risk factor for ADHD. In this study, mice heterozygous for a Snap25
allele and deficient in SNAP-25 expression were utilized to model genetic effects in
combination with prenatal exposure to nicotine to explore genetic and environmental (G
 E) factors and interactions.
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Striatal long-term depression (LTD) is a form of synaptic plasticity in which there
is a reduction in the glutamate released by cortical afferents onto striatal medium spiny
neurons (MSNs). The glutamatergic inputs activate ionotropic and group I metabotropic
glutamate receptors while dopaminergic inputs from the substantia nigra pars compacta
activate type-2 dopamine receptors (D2Rs), which collectively lead to post-synaptic
production of endocannabinoids that diffuse in a retrograde manner to activate presynaptic type-1 cannabinoid (CB1) receptors on to pre-synaptic terminals. The CB1
receptors initiate signaling cascades that lead to the long-term decrease in glutamate
release in pre-synaptic glutamate terminals. Using a high frequency stimulus (HFS)
electrophysiological paradigm for LTD induction in striatal MSNs, I first characterized
synaptic depression in four G  E groups representing mice prenatal nicotine exposed or
not or having Snap25 deficiency or not, that showed responses which could be divided by
cluster analysis into populations expressing LTD and short-term depression (STD). STD
is characterized by an initial decrease in amplitude in the response to the HFS followed
by near full recovery of the response within 30 minutes, while LTD occurs when the
initial decrease remains attenuated for at least 30 minutes. I found that prenatal exposure
to nicotine in Snap25 heterozygote mice produced a less robust LTD population and less
return to baseline in the STD population. Using receptor antagonists in the same HFS
electrophysiological paradigm I next examined the roles of dopaminergic D2Rs and
cannabinoid CB1Rs, both critical for LTD induction in the striatum. I found that prenatal
exposure to nicotine in Snap25 heterozygote mice produced a deficit in the D2Rdependent induction of LTD, although the CB1R involvement in plasticity was not
impaired.
From these results I developed the hypothesis that the impaired induction of LTD
due to prenatal exposure to nicotine in Snap25 heterozygote mice, could be related to
changes in D2R affinity and/or changes in the number of D2R receptors. This was
initially tested using a [35S]-GTPS binding assay to measure the agonist-stimulated
response of G-protein-coupled D2R receptors. Indeed, the agonist-stimulated response
was found to be reduced in Snap25 heterozygote mice prenatally exposed to nicotine,
which was consistent with a reduction in affinity of the agonist for the D2R receptor,
and/or reduced GPCR coupling to downstream signaling, but not with changes in the
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number of receptors. Next, a D2R agonist saturation binding assay, using [3H]-quinpirole
(a D2R selective agonist) followed by Scatchard analysis, showed that Snap25
heterozygote mice prenatally exposed to nicotine exhibited significantly lower affinity
(higher Kd) for D2R binding without a significant change in Bmax, which would reflect a
change in the number of receptors.
Collectively, these results support individually (G and E factors) and in
combination (G  E interactions), the HET genotype and prenatal nicotine exposure lead
to an impaired D2R GPCR signaling resulting from decreased agonist affinity and
possibly receptor-effector coupling of the D2R receptors These receptor binding
observations are consistent with the electrophysiological results showing that, in the
presence of a D2R antagonist, cortico-striatal circuits in Snap25 heterozygote mice
prenatally exposed to nicotine exhibit a significant deficit in LTD induction.
This study demonstrates that genetic conditions present in a Snap25
haplodeficient mouse model together with prenatal nicotine exposure can together alter
specific receptor affinity and signaling in dopaminergic D2 receptors (D2Rs) with
functional consequences in synaptic long-term depression (LTD). Since SNAP25 is a
candidate susceptibility gene for cognitive disorders such as ADHD and schizophrenia
and additionally prenatal exposure to nicotine is a candidate environmental risk factor for
ADHD, these studies have important translational relevance. The study also presents a
general set of experimental procedures by which potential G  E interactions can be
explored to determine if they alter receptor function and/or synaptic plasticity in specific
brain regions.
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Chapter 1 – Introduction
Basal ganglia circuitry
The basal ganglia are a set of nuclei found in the forebrain and midbrain. Before
discussing the neuronal circuitry of the basal ganglia, it is important to first describe its
basic anatomy. As shown in Fig. 1.1, the four principle nuclei of the rodent basal ganglia
are the striatum (Str), globus pallidus (GP), substantia nigra (SN) and subthalamic nuclei
(STN). The striatum in turn is subdivided into a dorsal region consisting of the caudate
and putamen, and a ventral region also referred to as the nucleus accumbens. The dorsal
and ventral striatum are not as well differentiated in rodents as they are in primates, so
the dorsal region is simply referred to as the dorsal striatum and ventral region as the
nucleus accumbens (NAc). The globus palladus (also referred to as the pallidum) consists
of an external segment, globus pallidus external (GPe), and internal segment, globus
palladus internal (GPi). The substantia nigra in turn consists of two regions, the
substantia nigra pars compacta (SNc) and substantia nigra pars reticulata (SNr).

Fig. 1.1: Rodent basal ganglia nuclei and connections. Figure shows key nuclei in the
basal ganglia and key connections between nuclei involved in inputs and output to the basal
ganglia. Figure does not show dopaminergic connections into the striatum from the SNc (Gerfen
and Surmeier, 2011)
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Fig. 1.1 shows that the striatum is the primary input nuclei for the basal ganglia
since it receives major excitatory glutamatergic input from all areas of cortex (referred to
as cortico-striatal inputs) and the thalamus (referred to as thalamo-striatal inputs). The
striatum also receives modulatory dopaminergic input from the SNc and serotonergic
input from the dorsal raphé (not shown). The striatum consists primarily of medium
spiny neurons (MSNs), which make up to 90% of the neurons in the striatum (Bolam et
al., 2000), which receive these glutamatergic inputs as well as modulatory inputs and
project inhibitory GABAergic outputs primarily to the GP and SNr. There are two D1like dopamine receptor types, D1 and D5 receptors and three D2-like dopamine receptor
types: D2, D3 and D4 receptors (Seeman and Van Tol, 1994; Vallone et al., 2000). All
D2-class receptors are expressed in MSNs in the dorsal striatum with D2 receptors
normally expressed ~2 fold higher that D3 and D4 receptors combined (Surmeier et al.,
1996). In this document D2 receptors (D2Rs) will specifically refer to the D2 receptor
subtype within the D2-like receptor class which in turn will be referred to as the D2-like
receptors. The MSNs make up to 90% of striatal neurons and divide into roughly two
equally expressed types of projecting neurons; those that express D1Rs known as
striatonigral or direct pathway neurons and those that express D2Rs known as
striatopallidal or indirect pathway neurons. A portion of D1R-striatopallidal and D2Rstriatonigral neurons express other dopamine receptors, for example, D1R-striatonigral
neurons express D3Rs, and D4Rs as well (Surmeier et al., 1996). As shown in Fig. 1.1,
direct pathway MSNs project primarily to the GP (GPi and GPe) and SNr, while indirect
pathway MSNs project primarily to the GPe. GPe neurons further project inhibitory
GABAergic outputs to the GPi and STN to complete the indirect pathway. The STN also
receives cortical glutamatergic input and projects glutamatergic outputs to the GPi and
SNr. The major basal ganglia output circuits are inhibitory GABAergic projections from
the GPi and SNr to the thalamus. There are also projections from the SNr to the superior
colliculus and pendunculopontine nucleus (PPN). MSNs in the NAc also receive
glutamatergic inputs from the amygdala and hippocampus and modulatory dopaminergic
inputs from the ventral tegmental area (VTA).
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Basal ganglia and behavior
The basal ganglia have long been associated with the coordination of movement.
This can be understood in part by the complementary roles played by the direct and
indirect MSN projections associated with movement (Gerfen and Surmeier, 2011). Fig.
1.2 is a diagram of basal ganglia inputs and outputs similar to Fig. 1.1, but simplified to
show the differences between activation of direct and indirect pathway MSNs and their
effect on motor control. As shown in Fig. 1.2, upon sufficient convergent glutamatergic
excitation either direct (left) or indirect (right) MSNs will be activated to make a
transition from the DOWN to the UP state and fire action potentials. Direct pathway
neurons (left) project directly to inhibit basal ganglia output targets (GPi or SNr). For
motor circuits from direct pathway MSNs, this results in a net inhibition of these output
GABAergic neurons, which project to the motor thalamus resulting in a net disinhibition
of these circuits. Through thalamocortical feedback from the motor thalamus to the premotor and motor cortex, this leads to promotion of movement. In contrast, indirect
pathway neurons (right) project indirectly to the GPe, which ultimately results in
activation of glutamatergic STN neurons onto the target outputs of the basal ganglia (GPi
or SNr). For motor circuits from indirect pathway MSNs, this results in a net excitation of
these output GABAergic neurons, which project to the motor thalamus resulting in a net
inhibition of these circuits. Through thalamocortical feedback from the motor thalamus to
the pre-motor and motor cortex, this leads to an inhibition of movement.
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Fig. 1.2: Activation of direct and indirect pathway neurons on motor movement.
Figure shows how activation of direct pathway MSNs (right) promotes movement and indirect
pathway (left) inhibits movement (green arrows- glutamate; red arrows – GABA; orange arrows –
dopamine; thickness of arrow represents relative amount of activation of each part of the
pathway)

Evidence that the basal ganglia are involved in control of movement has also been
found with its role in progressive neurodegenerative disorders such as Parkinson’s
disease and Huntington’s disease. Parkinson’s disease patients experience slowness of
movement, rigidity, tremors, and problems in maintaining balance. These symptoms are
related to degeneration of dopaminergic projection neurons from the SNc to the striatum
leading to a greater disruption of direct pathway MSNs versus indirect pathway MSNs.
This ultimately causes an increased GABAergic output to the thalamus and depression of
motor activity in the cortex and spinal cord. Animals supplied with dopamine
neurotoxins such as reserpine, 6-OHDA, or MPTP replicate both behavioral and circuit
changes associated with Parkinson’s disease supporting the role of the indirect pathway
in motor suppression (Shen et al., 2008).
Huntington’s disease is a progressive neurodegenerative disorder resulting from a
recessive dominant gene for the huntingtin protein involving excessive CAG repeats
within the gene, with usual onset in midlife with fatality within 15-20 years of onset. The
disease causes inclusion bodies to form in neurons starting in the striatum and then
spreading to other brain regions leading to excitotoxic cell death of neurons. These result
4

in involuntary movements called chorea’s as well as emotional and cognitive difficulties.
In contrast to the case in Parkinson’s disease, indirect pathway neurons are more heavily
disrupted causing them to be less active.
Additional evidence that the basal ganglia is involved with movement is provided
by studies in which dopamine and glutamate receptor agonists and antagonists are
injected in vivo into striata of animals, since these are both important neurotransmitters in
the striatum. Numerous studies have shown that D1R agonists perfused into the striatum
enhance movement while D1R antagonists inhibit movement; conversely, D2R agonists
perfused into the striatum inhibit movement while D2R antagonists enhance movement.
Both of these results support the roles of D1-direct pathway neurons in promoting
movement and D2-indirect pathway in inhibiting movement (David et al., 2005). Because
glutamate agonists activate both pathways in MSNs, their effects on movement have been
found to be more complex and more difficult to summarize (David et al., 2005) .
In addition to the evidence, described above, that the basal ganglia are important for
initiation of movement, recent work is bringing to light their role in the coordination of
movement. Currently there are at least two competing hypothesis as to what these roles
might be in terms of coordination of movement as further discussed below including
adjustment of motor sequences (Marsden, 1987), and selection of competing motor
programs (Mink, 1996).
As discussed, the basal ganglia receive cortical and thalamic inputs, which then
project to output structures including the GPi and SNr via the indirect and direct pathway
MSNs, which in turn make inhibitory GABAergic projections to the thalamus as well as
other output targets. There is evidence that these cortical and thalamic inputs and outputs
are connected topographically such that input and output connections to and from the
basal ganglia form quasi-independent control loops, which control different aspects of
movement (and other functions) (Bolam et al., 2000; Tisch et al., 2004). For example, the
skeletomotor loop links the premotor, supplementary motor, and motor cortex with basal
ganglia and motor thalamus to be involved with coordination of skeletal muscles.
Additional basal ganglia loops including the occulomotor loop associated with eye
movements and loops, which connect to cortical areas associated with somatosensory and
limbic functions. The limbic areas also receive inputs primarily from the ventral striatum
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(NAc), the hippocampus, and the amygdala, and have been shown to be involved in
reinforcement learning, a role for the basal ganglia distinct from direct motor
coordination.
We can compare the similarities and differences of competing hypotheses for the
overall role of the basal ganglia in the skeletomotor loop in coordination of movement of
limbs. One hypothesis is that the basal ganglia are involved in adjusting motor sequences
through opposing actions of the direct and indirect pathways (Marsden, 1987). This is
essentially a reiteration of the roles played by the direct and indirect pathway in their
disinhibition or inhibition of movement. In this model, cortical inputs and thalamic motor
outputs are filtered through the striatum to dynamically fine tune movements as they are
occurring by coordinating basal ganglia outputs in the GPi/SNr. A slightly more
sophisticated hypothesis is that the basal ganglia have a role in selecting competing motor
programs (Mink, 1996). One of the fundamental problems in motor control is
determining which motor program to execute at any given time for a given task or
situation, given that there may be many competing inputs from different brain regions.
The chorea involved in Huntington’s disease or response to dopaminergic medications
for Parkinson’s disease indirectly shows how conflicting signals may affect the
coordination of movement. As shown in Fig. 1.1, cortical inputs are delivered to the
striatum as well as the STN. In this model, a general motor program is sent to the STN
and the focused selection program is carried out through inputs in the striatum, which
either activate or inhibit this motor program through coordinated regulation of the direct
and indirect pathways. For example, if the desired program is to extend the arm, the basal
ganglia outputs will disinhibit motor outputs that are associated with extending the arm
and inhibit motor outputs that are associated with flexing the arm. Further research has
extended this paradigm to argue that the basal ganglia circuitry is involved in movement
selection in an adaptive manner such that beneficial movement sequences are enhanced
and those which are harmful, are suppressed. Mechanisms in neuronal plasticity, such as
long-term depression (LTD) and long-term potentiation (LTP), may be involved in
adjustments of basal ganglia circuitry involved in selection of motor programs. Some
preliminary research, which links LTD to behavior in the striatum is discussed below,
following a discussion of the process of LTD induction in the striatum.
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Striatal long-term depression (LTD) induction and signaling in MSNs
The mechanisms that underlie the induction of long-term depression (LTD) in the
striatum are the basis of many recent reviews (Di Filippo et al., 2009; Kreitzer and
Malenka, 2008; Lovinger, 2010; Surmeier et al., 2007). The following is a summary of
the process of induction of LTD as it is currently understood (Fig. 1.3). Long-term
decreases in synaptic efficacy, known as LTD, occur in MSNs in the striatum as a result
of high frequency stimulation (HFS) of the glutamatergic inputs or as the result of paired
activation of pre- and post-synaptic neurons known as spike timing dependent plasticity
(STDP). LTD is expressed as a decrease in the probability of glutamate release by
cortical or thalamic pre-synaptic inputs to MSNs. This is typically demonstrated by
measuring the frequency and amplitude of miniature excitatory post-synaptic currents
(mEPSCs) with frequency indicating the number of release events and amplitude
indicating the response to these events. Striatal LTD is characterized by a decrease in
mEPSC frequency, which is indicative of a pre-synaptic events and not amplitude, which
would be characteristic of a post-synaptic event (Choi and Lovinger, 1997a; Choi and
Lovinger, 1997b)
In the absence of glutamatergic input, the membrane potential of MSNs is near
the potassium equilibrium potential of~-85 mV referred to as the DOWN state. In
response to sufficient glutamatergic input, the MSN depolarizes to a potential of ~-55mV
referred to as the UP state, which is above the threshold for action potential generation.
The MSN must be in the UP state for the induction of LTD to occur (Choi and Lovinger,
1997a; Choi and Lovinger, 1997b). Sufficient glutamatergic input activates post-synaptic
group I metabotropic glutamate receptors (mGluRs), which are necessary for LTD
induction since their blockage by antagonists prevents LTD induction. Cav1.3 L-type
Ca2+ channel activation appears to be necessary for LTD induction, since blockage by
antagonists also prevents LTD induction (Wang et al., 2006). Sufficient dopaminergic
input to D2 receptors (D2Rs) is also necessary for LTD induction, since their blockage by
antagonists prevents LTD induction. Finally activation of pre-synaptically expressed
cannabinoid type-1 receptors (CB1Rs) is necessary for LTD induction, since their
blockage by antagonists also prevents LTD induction.
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Fig. 1.3 shows the basic model which has been developed for LTD induction,
which includes the so-called tri-synaptic circuit in which glutamatergic inputs converge
with dopaminergic inputs onto MSN spines. The glutamatergic and dopaminergic inputs
activate mGluRs and D2Rs. In addition, cholinergic interneurons may be also involved in
LTD induction. The MSN depolarized from the DOWN state to the UP state leads to
activation of Cav1.3 Ca2+ channels and Ca2+ signaling, which participates with the
mGluR and D2R activation in the production of post-synaptic endocannabinoids, which
transfer retrogradely to pre-synaptic cannabinoid CB1 receptors on glutamatergic input
terminals to cause prolonged inhibition of glutamate release. The role of D2Rs in LTD
induction in the striatum is well established, but their locus of action in this process has
not been fully elucidated (Lovinger, 2010). Since D2Rs are expressed in MSN spines,
activation of these D2Rs seem to be an obvious locus by which they are involved in LTD
induction (shown in Fig 1.3 as D2R path1). Evidence includes the observation that D2R
antagonists block LTD induction (Kreitzer and Malenka, 2005) as well as the additional
observation that nAChR receptors are implicated in LTD induction (Partridge et al.,
2002) possibly because of their inhibitory effects on dopamine release from
dopaminergic inputs. Another locus of action (shown in Fig 1.3 as D2R path2) involves
D2Rs expressed on cholinergic interneurons. According to this mechanism, a temporary
pause in cholinergic interneuron firing due to D2R suppression of cholinergic interneuron
firing in conjunction with glutamate excitation can lead to a temporary suppression of
acetylcholine release onto muscarinic M1Rs on MSNs, suppression of which may be
linked to the Cav1.3 Ca2+ channel activation involved in endocannabinoid production
(Wang et al., 2006). This research also identified the Cav1.3 Ca2+ channel as the critical
Ca2+ channel linked to LTD induction. Further research will be needed to elucidate
whether D2R involvement is through path1 or path2 or both. Clearly the interactions of
multiple transmitters, receptors, and channels are involved in LTD induction.

8

GLU

(A) GLU depolarizes MSN
(B) mGLU I, D2, M1 activation;
open up L-Ca channel,
PLC activation –> EC production

CB1

C

-

D2
nAChR

(C) Endocannabinoid retrograde
transmission bind CB1 -> inhibits GLU
release (LTD)

A
AMPA

NMDA
nAChR

A2A

+

mGLU I

B

D2R
path1

-

EC
Cav1.3

D2

DA
D2
nAChR

Spine

D2R
path2

-

-

Underlined – receptors
implicated in LTD

D2

D2

Cholinergic
Interneuron

M1

+
X

GABA
MSN

Fig. 1.3: Process of LTD induction in striatal MSNs. Schematic that illustrates how
MSN spines interface with glutamatergic and dopaminergic inputs as well as inputs from
cholinergic interneurons. The inset shows that following depolarization of an MSN by sufficient
afferent glutamatergic stimulation, L-type Cav1.3 Ca2+ channels along with mGluR and D2R
activation participate in the production of endocannabinoids which retrogradely transport to presynaptic CB1 receptors on glutamate terminals to lead to a long term decrease in the probability
of glutamate release characteristic of MSN LTD. The figure also shows alternative paths by
which D2Rs may be involved in LTD induction. D2R path1 in which binding of D2Rs expressed
in MSNs directly contributes to endocannabinoid production and LTD or D2R path2 in which
binding of D2Rs on cholinergic interneurons indirectly leads to suppression of acetylcholine
release onto cholinergic interneurons, which in turn contributes to activation of L-type Cav1.3
Ca2+ channels, contributing to endocannabinoid production.

Dopamine D2Rs are seven-transmembrane (7TM) G protein coupled receptors
(GPCRs) coupled to the Gi/o family of trimeric G proteins which is also the case for D3Rs
and D4Rs (Beaulieu and Gainetdinov, 2011). Group I mGluRs are GPCRs coupled to the
Gq family of trimeric G proteins (Luscher and Huber, 2010). Activation of both of these
receptors along with calcium influx from L-type Cav1.3 Ca2+ channels is necessary for
LTD induction (Castillo et al., 2012). The two major endocannabinoids synthesized in
MSN spines (Fig 1.3) are anandamide (Arachidonoylethanolomide; AEA) and 2-AG (2arachidonoylgylcerol) (Kano et al., 2009). It is unclear which of these two
endocannabinoids plays the principle role in LTD induction, but the current consensus is
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that 2-AG may play a larger role (Castillo et al., 2012). Fig 1.4 illustrates one of the
major anandamide synthesis pathways (top) and 2-AG synthesis pathway (bottom)
indicating how activation of both pathways are Ca2+ dependent (Kano et al., 2009). It has
also been established that one of the pathways of the synthesis of 2-AG is through Gq
protein activation of phospholipase Cβ (PLCβ). It is less well established how mGluR
signaling contributes to anandamide synthesis (Castillo et al., 2012). While D2Rs
activation is critical to the LTD induction process, since antagonism of D2Rs leads to
inhibition of LTD (Calabresi et al., 1992), its role (path1, path2 or both in Fig 1.3), in
endocannabinoid production has not been clearly established. In vivo microdialysis
measurements of anandamide in the striatum have shown that D2R activation by D2R
agonists produces a multifold increase in anandamide indicating that D2R activation may
be involved in endocannabinoid production during LTD induction (Giuffrida et al.,
1999). As with mGluR, it is unclear how D2R signaling may influence anandamide
synthesis. Given that one of the downstream effectors of D2Rs, as with mGluRs is PLCβ,
this may be one mechanism by which D2R activation could be involved in 2-AG
synthesis (Lee et al., 2004; Mathur and Lovinger, 2012).
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Fig. 1.4: Interaction of D2R and mGluR signaling with endocannabinoid production
in MSNs. Top shows one synthesis pathway for endocannabinoid Anandamide
(Arachidonoylethanolomide; AEA) as well as possible mGluR, D2R and VGCC (L-type Cav1.3
Ca2+ channel) interactions with Anandamide synthesis. Bottom shows one synthesis pathway for
endocannabinoid 2-arachidonoylgylcerol (2-AG) as well as possible mGluR, D2R and VGCC (Ltype Cav1.3 Ca2+ channel) interactions with Anandamide synthesis. Black arrows show activation
of D2R downstream effectors as well as endocannabinoid synthesis pathways. Red lines show
inhibition of D2R downstream effectors. Blue arrows show activation of mGluR downstream
effectors. Dotted lines – black and blue, unclear how activation of D2Rs and mGluRs influences
anandamide synthesis. Abbreviations: AC, adenylyl cyclase; cAMP, cyclic AMP; DAG,
diacylglycerol; DAGL, diacylglycerol lipase; NAT, N-acyltransferase; NAPE, N-acylphosphatydlethanolamine; NAPE-PLD, N-acyl-phosphatydlethanolamine-hydrolyzing
phospholipase D; PLCβ, phospholipase Cβ; PE, phosphatidylethanolamine; PKC, protein kinase
C; PL, phospholipid. Chemical drawings of Anandamide and 2-AG, obtained from (Ueda et al.,
2013)

The synthesis of endocannabinoids on the post-synaptic MSNs is followed by
their transfer retrogradely to pre-synaptic CB1Rs expressed on glutamate terminals. The
process of transfer to the pre-synaptic glutamate terminals has not been fully resolved as
to whether it may involve carrier proteins or simple diffusion (Kano et al., 2009). Signal
transduction through CB1Rs, which are Gi/o-coupled GPCRs, leads to reduction in the
release of glutamate from pre-synaptic terminals leading to LTD. Why this transduction
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process leads to sustained changes in glutamate release is currently not fully understood
(Castillo et al., 2012; Mathur and Lovinger, 2012).
The D2R has two variants expressed by alternate splicing of the same gene, D2S
(S=short; 414 amino acids) and D2L (L=long; 443 amino acids). The D2S is
predominantly expressed pre-synaptically on input terminals including glutamatergic,
dopaminergic, and cholinergic terminals on MSNs (Fig. 1.3) and D2L is expressed postsynaptically on MSNs spines (Usiello et al., 2000). The D2 receptor can exist in either a
state of low or high affinity for dopamine (D2Low or D2High, respectively) and the relative
levels of each affinity state have been investigated (Seeman et al., 2006). The D2Low state
represents the condition where the D2R GPCR is uncoupled from the heterotrimeric
protein (Gαi/o,Gβ,Gγ) and the D2High state represents the condition where the D2R GPCR
is coupled and the latter state is more readably able to bind dopamine and D2R agonists
(van Wieringen et al., 2013). Studies using homogenized rat striata suggest that ~0.77 of
D2Rs are normally in the D2High state (Seeman et al., 2006).
D2R receptors have important downstream signaling pathways in addition to
those associated with endocannabinoid production. A brief summary of the major
pathways associated with D2R signaling based upon information provided in recent
reviews (Beaulieu and Gainetdinov, 2011; Cho et al., 2010; Yao et al., 2008) is presented
below and illustrated in Fig. 1.5. Prior to D2R agonist binding, the trimeric G protein α
subunit will be bound to GDP, and tightly associated with the β and γ subunits. There is
some controversy as to whether the trimeric G protein complex can be pre-coupled to the
D2R receptor prior to agonist binding, or whether it requires agonist binding in order to
be coupled to the D2R. In either case, upon D2R agonist binding, the trimeric G protein
complex associates with the D2R through the third intracellular loop and C terminus, and
undergoes conformational changes, which allow an exchange of GTP for GDP on the Gα
subunit causing the Gα subunit to become activated and to dissociate from the Gβγ
subunit complex. Both the activated Gα subunit as well as Gβγ subunit complex can then
trigger secondary downstream signaling pathways. The Gα subunit has intrinsic GTPase
activity, which allows it to hydrolyze GTP permitting a return to the inactive state bound
to the Gβγ subunit complex. Important regulators of G protein signaling (RGSs) can
accelerate the rate of GTP hydrolysis. As long as agonist binding of the D2R remains,
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multiple sets of heterotrimeric G proteins can be activated, amplifying the downstream
signaling. Agonist binding further triggers recruitment of G protein receptor kinases
(GRKs), which phosphorylate specific sites on the D2R intracellular loops allowing βarrestins to bind the D2Rs and to the D2R in an activity-dependent manner. The βarrestins also trigger clathrin-dependent internalization and recycling of the D2R
receptors. Protein kinase A (PKA) and protein kinase C (PKC) also phosphorylate sites
on the D2Rs and also may be involved in regulation of D2R signaling.
Since D2Rs are coupled to the Gi/o family of trimeric G proteins, activation the
Gα subunit inhibits adenylyl cyclase (AC) activity. This results in a net inhibition of PKA
and its targets including those involved with dopamine and the 32kDa cAMP-regulated
phosphatase DARPP-32. Inhibition of DARPP-32 depends upon de-phosphorylation by

protein phosphatase 2B (PP2B, or calcineurin), which is a calcium-dependent process.
The D2R Gβγ subunit complex as discussed previously activates PLCβ and so
may be involved in 2-AG endocannabinoid synthesis. The Gβγ subunit complex is also
involved in other PLCβ-dependent signaling processes such as the activation of PKC and
2+

inositol 1,4,5-trisphosphate (IP3)-dependent opening of IP3 Ca

channels expressed in the

endoplasmic reticulum (ER) lumen. The resultant release of Ca2+ is involved in PP2B
activation as well as the activation of Ca2+-calmodulin dependent protein kinase II (CAMKII).
The PLCβ signaling is also negatively coupled to L/N Ca2+ channel opening and it

promotes the opening of G-protein-coupled inward rectifying potassium (GIRK)
channels, both of which act to inhibit the excitability of MSNs.
Finally, β-arrestin signaling, associated with D2R desensitization and receptor
internalization, is involved, through protein phosphatase 2A (PP2A) activation, in the
suppression of signaling associated with Akt (Protein kinase B; PKB).
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Fig. 1.5: Dopamine D2R signaling pathways. Adapted from (Beaulieu and
Gainetdinov, 2011). Left shows D2R Gαi/o and Ca2+ signaling pathways. Center shows D2R Gβγ
signaling pathways. Right shows β-arrestin2 signaling pathways. Blue arrows show activation of
D2R downstream effectors. Red T lines show inhibition of D2R downstream effectors.
Abbreviations: AC, adenylyl cyclase; Akt, also referred to as protein kinase B; cAMP, cyclic
AMP; DAG, diacylglycerol; DARPP-32, dopamine and cAMP regulated phosphoprotein of 32
kDA; βArr2, β-arrestin2; CamKII, Ca2+ -calmodulin dependent protein kinase II, GSK-3α/β,
glycogen synthase kinase 3α/3β; IP3, inositol 1,4,5-trisphosphate; PLCβ, phospholipase Cβ;
PKA, protein kinase A; PKC, protein kinase C; PP1, protein phosphatase 1; PP2A, protein
phosphatase 2A; PP2B, protein phosphatase 2B.

Striatal LTD and behavior
Given the ubiquity of LTD in the striatum, an increasingly important research
question has been to try to identify how LTD might be linked to behavior (Lovinger,
2010). These studies require linking animal behavioral experiments with in vivo or ex
vivo electrophysiology recordings in order to show that the behavioral changes are
connected to changes in plasticity. For example, one study found differences in ability to
undergo LTD in cortico-striatal circuits in association with the acquisition and
consolidation phases of skilled learning task (Yin et al., 2009). In this study, mice were
implanted with multi-electrode arrays in which in vivo recordings of the dorsal medial
striatum (DMS) and dorsal lateral striatum (DLS) MSNs were recorded simultaneously
while the mice learned a task of remaining on rotorod (rotating bar) for repeated trials
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each day for several days. It was found that during the early training phase (day 1) DMS,
but not DLS, neurons increased their firing rates simultaneous with improvement of the
skill as measured in latency (seconds) remaining on the rotorod compared to the rates
recorded from the same mice prior to training (non-trained naïve controls). During the
late training phase (day 8), DLS neurons, but not DMS neurons, increased their firing
rates compared to naïve controls but this did not correspond with improvements in
latency. This indicated that DMS and DLS firing rates correlated with different time
periods of the task. To examine possible changes in striatal plasticity associated with
these changes in firing rates, ex vivo slice recordings were performed on representative
naïve controls as well as early and late trained mice, which had undergone the same
learning tasks. In both the DMS and DLS neurons an experimental paradigm known as
the LTD saturation task was performed. This paradigm consisted of a 10 minute baseline
set of population spike recordings delivered at half maximum stimulus followed by two 1
second trains of 100 Hz at maximum stimulus followed by 20 minute recordings at half
maximum stimulus during which the population spike would typically decrease in
amplitude compared to the baseline and partially recover to ~0.8 of the previous baseline.
The same HFS train and 20 minute recording was repeated three times for a total of 4
HFS trains interspersed with 20 minute recovery periods for a 120 minute total recording
time. The object of this paradigm was to determine when the responses to HFS reached
saturation in which the response following a given stimulus train in the series failed to
produce a significant depression of the population spike over that from the previous
stimulus train. This was considered to be a saturation of the LTD response. It was found
that for naïve mice, DMS slices required more HFS trains to reach saturation than DLS
slices and thus were more malleable to modification in the naïve and early learning stages
and this corresponded with the increased firing rates in early stages found with the in vivo
recordings. Conversely for late stage mice, DLS slices required more HFS trains than
DMS slices and were more malleable to modification in the late learning stages. These
changes were interpreted to imply that the differences in firing rates recorded in vivo in
the DLS versus the DMS neurons involving behavioral learning correlated to changes in
responses to LTD saturation in ex vivo slices of the same animals, so that behavior could
be potentially linked to LTD.
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Another recent study compared knockout mice deficient in adenlylyl cyclase 5
(AC5), which is highly expressed in MSNs, where it serves as a downstream effector of
D2Rs, to WT controls for different behavioral tasks as well as for changes in
electrophysiology including LTD (Kheirbek et al., 2009). In a response learning task
known to be dorsal striatum-dependent, in which mice were required to swim to locate a
hidden platform arm by making the same body turn (left or right) each time, AC5
knockouts were found to take longer to acquire the success criteria (9/10 correct choices)
than controls, during both the initial acquisition as well as during reverse learning where
the opposite body turn was required, with a 2-3 fold increase in the number of trials for
the AC5 knockouts to achieve success versus the controls. Similar to the previous
research on DLS versus DMS (Yin et al., 2009), the latency to fall off of a rotorod was
significantly less for AC5 knockouts versus controls, for latencies during daily trials,
extended over three days. In subsequent whole-cell voltage-clamp recordings, differences
were not found in basal firing or paired pulse facilitation between AC5 knockouts and
controls. However when subject to four 1 second trains of 100 Hz at maximum stimulus
intensity separated by 10 seconds, with 10 minutes of baseline recordings at half
maximum stimulus prior to the 100 Hz trains, and 30 minutes of recordings following the
100 Hz trains, it was found that both AC5 knockouts and controls underwent a brief drop
in amplitude following the 100 Hz trains, relative to the baseline recordings, but the AC5
knockouts returned to the baseline levels after 30 minutes, while the controls underwent a
mild LTD of ~0.80 of the baseline levels. This experiment like the previous one,
demonstrates how behavioral changes may be correlated with changes in LTD. Both of
these studies also show how changes in response to LTD due to genetic differences or
striatal location, may be related to and partially underlie associated behavioral changes.

Gene-environmental factors and interactions in neuropsychiatric diseases
It has been known for some time that a given trait expression is a product of both
the genes underlying a particular trait as well as environmental conditions. For most
traits, which are products of multiple genes and environmental factors, this is seen in the
mathematically described heritability of a trait (h2) where h2 = genotypic
variance/phenotypic variance (Falconer, 1989). A highly heritable trait is one in which
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the underlying genes make a larger contribution to the trait’s expression than do
environmental factors. The heritability of a trait varies greatly because a given trait may
be under the influence of many genes and diverse environmental factors. Furthermore,
trait expression can be understood to be influenced both by the genetic coding as well as
environmental factors. For example, changes in transcription factors can influence the
amount of protein that a gene will express. Equivalently, changes in environmental
conditions can modulate the levels of transcription factors available and thus influence
protein expression. Environmental factors can be distinguished to some extent by whether
they have their effects in utero, during early postnatal development, or throughout the
lifetime of an organism.
It is not surprising that both genes and environmental conditions are involved in
the development of cognitive capacities and that both can contribute to neuropsychiatric
disorders. There is a growing body of research dedicated to determining the crucial role
played by gene-environmental interactions in neuropsychiatric illnesses including
depressive disorders, ADHD, schizophrenia, obesity, and substance abuse (Wermter et
al., 2010). It has been known for some time that there are specific genes associated with
susceptibility to certain neuropsychiatric disorders. At the same time, it is postulated that
given a set of susceptibility genes for a given disorder, the likelihood of getting a specific
disease will increase in the presence of specific environmental factors. A common
example of the interaction of genes and environmental conditions in a nonneuropsychiatric disease is phenylketonuria (PKU). PKU results from a recessive
mutation in which the gene for phenylalanine hydroxylase (PAH) that is necessary to
convert the amino acid phenylalanine to tyrosine is non-functional. If PKU is undetected,
phenylalanine accumulates and is converted to phenlyketone, which accumulates and if
untreated can lead to seizures and mental retardation. Fortunately, detection at birth, and
the use of phenylalanine-deficient diets can prevent the development of PKU. Thus, PKU
illustrates how a gene mutation (PAH) combined with an environmental effect
(consumption of phenylalanine) can lead to a disease PKU. Gene-environmental (G  E)
interactions in neuropsychiatric disorders are harder to identify than the simple case of
PKU. This is due to the polygenic nature of neuropsychiatric disorders such as attention
deficit hyperactivity disorder (ADHD), schizophrenia, and autism, in which the disorder
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appears to be the product of the combined effects of many genes and not the effect of a
small number of dominant genes as was the case in PKU.
A number of recent studies have examined the relationship of G  E factors in
other disorders. An early set of studies (Caspi et al., 2002; Caspi et al., 2003) showed that
a polymorphism of the gene encoding for monoamine oxidase A (MAOA) combined with
childhood maltreatment was associated with conduct disorder and antisocial personality.
Follow-up studies failed to replicate the findings, but a meta-analysis of multiple studies
still showed a significant interaction (Kim-Cohen et al., 2006). Several studies have
linked obesity to G  E interactions, including one which linked a polymorphism in the
fat mass and obesity associated gene (FTO), and low amounts of physical activity
(Rampersaud et al., 2008). Another study found that a gene variant for the serotonin
transporter and environmental adversity were involved in depression (Uher and
McGuffin, 2008). Additionally, as described below, there is evidence for G  E
interactions in attention deficit/hyperactivity disorder (ADHD) and schizophrenia. These
studies provide impetus for studies with animal models to further probe the role of the
interaction of G  E factors on behavior and neural circuits, which may underlie
neuropsychiatric as well as other disorders.
G  E interactions can be evaluated by performing analysis of variance (ANOVA)
between groups of animals with differences in genes and environmental conditions. For
example, as described further in the Methods, I have used a 2  2 design to evaluate the
interactions of genotype and environment using Snap25 heterozygote knockout male
mice (HET) bred with wild type C57BL/6J female mice (WT) (genotype control) under
either saccharine (environmental control) or prenatal nicotine exposure (PNE) conditions
during pregnancy to produce four experimental groups of mice representing genotype
(HET)  environmental (PNE) interactions. A two-way ANOVA was used evaluate if
there are main genotype (HET v WT) factors, main environmental factors (PNE v Sac),
and/or factors due to gene-environmental interactions. Analysis of a given experiment
will reveal whether combinations of distinct genotypic and/or environmental factors as
well as gene-environmental interactions contribute to the comparative differences of the
experimental groups.
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Role of SNAP-25, and prenatal nicotine exposure in ADHD
Attention deficit/hyperactivity disorder (ADHD) is a common, albeit
heterogeneous, neuropsychiatric disorder with a prevalence of greater than 5% worldwide
(Faraone et al., 2003; Polanczyk et al., 2007). ADHD is first detected in childhood and
often extends into adulthood (Biederman et al., 2011) and is characterized by the
debilitating social and behavioral symptoms of excessive inattention, hyperactivity, and
impulsivity (American Psychiatric Association, DSM IV-TR, 2000).
The role of the basal ganglia and the dorsal striatum in particular in ADHD is well
established (Swanson et al., 2007). For example, in human ADHD patients, the caudate
is smaller than these structures in control groups, and prefrontal cortex to striatal
networks have been found to be functionally less active compared to controls (Swanson
et al., 2007). Genetic association studies have demonstrated that ADHD has strong
heritability, although it appears to have a complex multigenic etiology (Faraone et al.,
2005; Faraone and Mick, 2010) consistent with small effects due to multiple genes.
Multiple studies have consistently found certain gene variants implicated in ADHD
including the SNAP25 gene, several dopamine related genes (DRD4, DRD5, DAT,
dopamine β-hydroxylase) as well as serotonin related genes (Faraone et al., 2005). Some
of these candidate ADHD genes, such as DRD4 and DAT, are directly involved in
cortico-striatal circuitry. While the striatum has traditionally been directly associated
with motor control, it has increasingly been seen to be critical in other forms of behavior
as well (Schultz et al., 2003). The therapeutic response to psychostimulant treatment has
implicated the involvement of dopamine and norepinephrine systems with implications
for cortico-striatal circuitry and executive function (Swanson et al., 2007). Recent
imaging studies further suggest the contribution of a wide range of neural networks to the
diversity of ADHD symptoms (Castellanos and Proal, 2012). Based on the evidence for
alterations in dopaminergic neurotransmitter systems, a number of genes that encode
proteins involved in dopamine transmission have been examined in genetic studies and
have been shown to be associated with ADHD (Faraone and Mick, 2010).
The SNAP25 gene is one candidate susceptibility gene for ADHD. SNAP25
encodes the pre-synaptic protein SNAP-25, which is one of the t-SNAREs that have been
shown to play a role in Ca2+-dependent vesicular fusion and is thus a protein critical to
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evoked neurotransmitter release (Jahn and Scheller, 2006; Rizo and Sudhof, 2012). In
order for neurotransmitter to be released from a pre-synaptic terminal, a neurotransmitterfilled vesicle must fuse with the pre-synaptic membrane. This fusion process requires the
interaction of target-membrane-associated-soluble N-ethylmaleimide fusion protein
attachment protein receptor proteins (t-SNAREs) and vesicle-membrane-associatedsoluble N-ethylmaleimide fusion protein attachment protein receptor proteins (vSNAREs). These SNARE components interact to form a 4 barrel coiled-coil structure,
which makes a zipper-like interaction to reduce the distance between the plasma
membrane and vesicular membrane thereby allowing the two membranes to fuse and
form a fusion pore through which neurotransmitter is released into the synaptic cleft.
Furthermore, a number of studies have implicated a role for environmental toxins,
including prenatal exposure to tobacco smoke and alcohol as well as and postnatal lead
exposure, as significant risk factors for ADHD (Braun et al., 2006; Linnet et al., 2003).
Given the evidence for both a genetic contribution from the SNAP25 gene and an
environmental contribution from prenatal nicotine in ADHD, both of these factors have
been studied in this research to examine the potential effects of G  E factors and
interactions in synaptic depression in a Snap25 null mouse mutant.
Experiments with rats have shown that prenatal nicotine exposure affects nACh
receptor expression and activity as well as dopamine release in the striatum relative to
controls (Gold et al., 2009). Thus, one potential target of prenatal nicotine exposure
could be nACh receptors in the striatum with subsequent effects on dopamine release.
Several subtypes of the nAChR are expressed on striatal glutamate and dopamine
terminals, as well as on MSNs and on cholinergic interneurons themselves (Quik et al.,
2007). Importantly, nAChR antagonists also have been shown to block LTD induction,
so nAChRs, along with D2Rs, mGluRs, and CB1Rs are necessary for LTD induction
(Partridge et al., 2002). Using an adenovirus carrying a cre-inducible channelrhodopsin
gene targeted to cholinergic interneurons, Cragg and colleagues (Threlfell et al., 2012)
were able to demonstrate that cholinergic interneurons can directly activate dopamine
release through nAChRs expressed on dopaminergic terminals. Dani and colleagues have
demonstrated similar effects with nicotine (Zhang et al., 2009). Another study found that
prenatally nicotine-exposed mice exhibit an upregulation of nAChR binding and
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decreased dopamine efflux in the striatum compared to controls for adolescent (PN42)
versus younger animals (PN10) (Gold et al., 2009). This study also found changes in
cortical and thalamic responses of nAChR receptors, both of which are expressed on
cortical and thalamic glutamatergic terminal inputs to the striatum, and thus could have
additional affects on the LTD induction pathway in the striatum. Thus multiple studies
support a role for nAChRs in modulating dopamine release, involvement in LTD both of
which could be affected by prenatal nicotine exposure.

Snap25 animal models for ADHD
Animal models have been invaluable in the characterization of mechanisms that
may underlie human neuropsychiatric disorders. The coloboma mouse mutant,
heterozygous for a ~2 cM deletion of chromosome 2 (Cm) that encompasses the gene
encoding SNAP-25, is one of several experimental constructs that meet the criteria of a
valid animal model of ADHD (Fan et al., 2012; Wilson, 2000). This SNAP-25
haplodeficient mouse, which exhibits a 50% reduction of SNAP-25 expression (Hess et
al., 1992), displays certain hallmarks of ADHD (Fan et al., 2012) including hyperactivity,
which is ameliorated by the psychostimulant amphetamine (Hess et al., 1996), as well as
inattention and impulsivity (Bruno et al., 2007). Moreover, the hyperkinesis and
amphetamine responsiveness of these mutants have been shown to be mediated through
D2 dopamine receptors (Fan and Hess, 2007; Fan et al., 2010). Interestingly, the robust
hyperactive behavior of this mutant appears not to be recapitulated in heterozygote
Snap25 null mutants (Washbourne et al., 2002), although it was recently reported that
these mice do display more subtle behavioral deficits and a susceptibility to seizures
(Corradini et al., 2012). Additionally, using microdialysis to assay dopamine efflux in
freely moving coloboma mice, Hess and colleagues have demonstrated markedly
increased basal levels of extracellular dopamine in the striatum that is further increased
by amphetamine administration (Fan and Hess, 2007).
Both genetic and environmental factors have been shown to contribute to the
inattentive, hyperactive/impulsive, and combined subtypes of ADHD (Swanson et al.,
2007; Thapar et al., 2007). Given that G  E interactions are very complex in
heterogeneous human populations, an animal model based on well-defined genetics and
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pharmacological exposure is proposed in this research that should provide better
understanding of this interaction and the mechanisms by which it contributes to ADHD.

Snap25 and Schizophrenia
Social impairment, along with other cognitive and emotional dysfunctions, is
characteristic of schizophrenia (American Psychiatric Association, DSM IV-TR, 2000).
There are a range of symptoms associated with schizophrenia, as well as distinct subtypes
to the disorder. Among these symptoms are multimodal hallucinations (auditory, visual,
olfactory, etc.) as well as delusions including an extreme sense of being persecuted, in
different degrees depending on the subtype of the disorder.
In addition to ADHD, SNAP25 has been identified as a candidate gene for
schizophrenia based upon genome wide analysis (Lewis et al., 2003). A transgenic
mouse bearing a variant of the human disrupted in-schizophrenia (DISC1) gene encoding
a truncated DISC1 protein associated with schizophrenia, also exhibit a 30% decrease in
expression of SNAP-25, which may contribute to deficits in social interactions, as well as
to the spontaneous hyperactivity found in these mutants (Pletnikov et al., 2008). In a
Snap25 gain of function mutant mouse, Bdr, proposed to model elements of
schizophrenia (Jeans et al., 2007), prenatal exposure to stress not only enhances
sensorimotor gating defects, but also produces deficits in social interaction and reveals
depression-like behavior (Oliver and Davies, 2009). Thus, there is evidence that suggests
a role for Snap25 in mice with schizophrenia-like behaviors.

Additional background data on Snap25 null mutant mice
Unpublished in vivo microdialysis measurements of glutamate and dopamine in
the striatum of heterozygous Snap25 null mutants (Snap25 +/- mice; equivalent to the
HET/Sac group used in this research) performed by Dr. Ellen Hess and colleagues found
that these mice had significantly increased evoked extrasynaptic dopamine release, but
lower glutamate release in response to potassium-induced depolarization when compared
to wild type controls (Fig. 1.6). Amphetamine also increased dopamine release in the
Snap25 null mutants relative to controls (Fan, Wilson, Hess, unpublished observations).
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These findings indicate that the Snap25 null mutants utilized in this study, exhibit
hyperdopaminergic together with hypoglutamatergic transmission. The potential
implications of these phenotypic differences on the results of this research are presented
in the Discussion.
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Fig. 1.6: In vivo microdialysis measurements show hyperdopaminergic and
hypoglutamatergic phenotype of HET mice vs. controls.

Independent behavioral research was performed in parallel to this work to test for
G  E interactions in behavior by using the same adolescent (PN35 – PN50) Snap25 null
+/-

+/+

mutant heterozygotes (Snap25 ) and control littermates (Snap25

) (Washbourne et al.,

2002) and the same prenatal nicotine exposure paradigm (Paz et al., 2007) as is used in
this research and recently published (Baca et al., 2013). The four G  E experimental
groups were assessed for spontaneous locomotor activity in a novel environment and
their social interaction phenotypes were determined (Fig. 1.7A, B). For these behaviors,
the mice were tested during their nocturnal active phase. Cumulative data collected for
the locomotor activity over 180 minutes is shown in Fig. 1.7A. The activity of the
HET/PNE group was found to be significantly greater (~1.5 – 3.5 fold) than the other
groups (Fig. 1.7A) indicating increased locomotor activity among the HET mice exposed
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to prenatal nicotine. Importantly, significantly increased activity of the HET control
group compared to WT mice was not observed, consistent with an initial report on the
behavior of these mice (Washbourne et al., 2002). However, in agreement with earlier
findings (Paz et al., 2007), the PNE treatment did result in greater activity of the wild
type offspring (WT/PNE group) compared to saccharine-treated wild type controls
(WT/Sac group; ~2.2 fold, p <0.01). Nevertheless, the significant ~3.5 fold increase of
spontaneous activity observed in HET/PNE groups compared to WT/Sac groups was
more comparable to the hyperactivity of coloboma mutants discussed above, which was
3-4 fold greater compared to their control wild type littermates when tested over a similar
time course (Hess et al., 1996).

Fig. 1.7: Locomotor activity and social interaction in the four G  E groups.
A Locomotor activity of animals from the four G  E experimental groups were monitored in
individual photocell activity cages. Values shown (mean ± SEM, n = 4 – 5 animals) represent
beam breaks recorded over a 180 minute period. A two-way ANOVA of the data obtained from
the two genotype (HET v WT)  two prenatal treatment (PNE v Sac) group comparisons revealed
a significant effect of genotype (F(1,14) = 14.11, p < 0.01), treatment (F(1,14)=51.76, p <0.001), as
well as a significant interaction of genotype  treatment (F(1,14)=4.70, p <0.05). Post-hoc revealed
HET/PNE group had significantly greater activity than other groups (p < 0.01) and WT/PNE
significantly greater than the WT/Sac control group (p < 0.01). B Social interaction of animals
from the four G  E groups was monitored individually. Values shown (mean ± SEM, n = 7 – 8
animals) represent time spent interacting with novel mouse. A two-way ANOVA revealed a

significant effect of genotype (F(1,26)=20.80, p < 0.001), treatment (F(1,26)=10.82, p <0.01),
and a significant interaction of genotype  treatment (F(1,26)=6.02, p <0.05). Post-hoc tests
for social interaction revealed HET/PNE group interacted significantly less frequently than other
groups (p < 0.001).
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To examine a more complex behavior, the four groups of mice were subjected to
a social interaction test in which the mice were assessed for the amount of time spent
with an unfamiliar mouse of the same sex and age (Fig. 1.7B). The social interaction of
the HET/PNE group was found to be significantly less (~0.3 - 0.4 fold) than the other
groups (Fig. 1.7B) indicating reduced social interaction among the HET mice exposed to
prenatal nicotine.
When taken together, these results provided evidence that prenatal exposure to
nicotine has a pronounced effect on the behavior of Snap25 heterozygote mutant mice
that is greater than its effect on wild type littermates, consistent with the idea that a
SNAP-25 deficiency during brain development confers a vulnerability to the behavioral
consequences of in utero nicotine exposure. In this study, I followed up on these
behavioral findings by investigating the cellular and molecular mechanisms that underlie
long-term synaptic plasticity.
This chapter has provided an overview of basal ganglia function; striatal LTD
induction; a potential relationship between striatal LTD and behavior; some examples of
the interaction of gene-environmental interactions and neuropsychiatric disorders;
evidence that Snap25 deficiency and prenatal nicotine exposure are factors in ADHD and
schizophrenia; and finally the use of animal models to shown how these genetic and
environmental factors may be involved in the etiology of these disorders. The hypothesis
of this research is that gene-environmental factors and interactions deriving from Snap25
deficiency and prenatal nicotine exposure lead to long term impairments in D2 receptor
functionality in striatal MSNs. I show that this occurs by impairments of D2 receptor
affinity and possibly receptor-effector coupling leading to functional impairments of the
process of striatal LTD induction. The methods used and results of electrophysiology and
binding studies which support this hypothesis as well as a discussion of the implications
of these results are presented in the chapters that follow.

25

Chapter 2 – Hypothesis and Specific Aims
Genes and environmental conditions interact in the development of cognitive
capacities so both would be expected to play a role in neuropsychiatric disorders. As
outlined in the Introduction, the gene for the SNARE protein, SNAP-25, has been
identified as one of the candidate susceptibility genes for ADHD as well as for
schizophrenia (Faraone and Mick, 2010). Similarly, the environmental risk factor of
maternal smoking has been associated with ADHD (Linnet et al., 2003). Deficits in the
striatum have been implicated in ADHD, and models have been proposed to account for
changes in attention, motor functions, and behavior due to alterations in the striatum and
specific genes are implicated in some of these (Swanson et al., 2007). This study aims to
determine how genetic contributions from a Snap25 haplodeficient mouse model together
with prenatal nicotine exposure may together alter specific receptor affinity and signaling
in dopaminergic D2 receptors (D2Rs) as well as synaptic long-term depression (LTD),
which is in part dependent on these receptors. The linkage of Snap25 haplodeficiency has
to ADHD has been studied extensively in the well established coloboma mouse model of
ADHD, which includes Snap25 haplodeficiency, by Michael Wilson, Ellen Hess and
other researchers, which provide a foundation for further studies (Fan et al., 2012). Thus,
this interaction of genetic and environment factors should provide insight into
mechanisms contributing to cognitive disorders such as ADHD and schizophrenia. The
study also presents a general set of experimental procedures by which potential geneenvironmental interactions can be explored to determine if they alter receptor function
and/or synaptic plasticity in specific brain regions.
The induction of LTD was characterized in the striatum as early as 1992 using
high frequency stimulus (HFS) paradigms, based on both extracellular (field potential)
and intracellular (voltage-clamp) techniques (Calabresi et al., 1992). These initial
experiments found that a 100 Hz HFS paradigm as described below was capable of
inducing LTD using both recording techniques. Furthermore, the use of D2R antagonists
implicated a role for dopaminergic D2Rs during the induction paradigm. Subsequent
work has identified several other receptors including the pre-synaptic CB1 receptors as
also necessary for LTD induction (Surmeier et al., 2007). Since both the D2 and CB1
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receptors have been established as important elements in LTD induction, these two
receptor types were chosen as important candidates to probe the G  E factors and
interactions involved in LTD induction. An additional basis for examining D2Rs was
that a preliminary microdialysis study identified Snap25 haplodeficient mice as
hypoglutaminergic and hyperdopaminergic as discussed in the Introduction, suggesting
that the normal glutamatergic and dopaminergic interactions found in LTD may have
been affected by the Snap25 gene.
Experiments in all specific aims utilized a 2  2 design, which was developed to
evaluate the factors and interactions of genotype and environment on cortico-striatal
signaling. Snap25 heterozygote knockout male mice (HET) (Washbourne et al., 2002)
were bred with wild type C57BL/6J female mice (WT) under either saccharine or
prenatal nicotine (PNE) bottle-fed conditions during pregnancy according to standard
protocols to produce four G  E experimental groups of mice representing genotype
(HET)  environmental (PNE) interactions designated as: WT/Sac, WT/PNE, HET/Sac
and HET/PNE. Wild type (WT) and heterozygous (HET) offspring were evaluated
between 35-50 days of age (average ~PN 40 for each group) to model an adolescent stage
of brain maturation.

The following hypothesis and specific aims are proposed:

Hypothesis: Gene-environment factors and interactions in Snap25 deficiency and
prenatal nicotine exposure lead to long-term impairments in D2 receptor affinity in
striatal medium spiny neurons resulting in impairments of the process of striatal
LTD induction.

Aim 1-To characterize gene-environment factors and interactions in long-term
synaptic depression using a high frequency stimulus (HFS) LTD induction paradigm.
The effect of G  E factors and interactions in a Snap25 haplodeficient mouse
model was measured in the four G  E experimental groups. A high frequency stimulus
(HFS) paradigm in the dorsal striatum is used to induce long-term (LTD) or short-term
(STD) depression as has been previously reported (Lovinger et al., 1993). The D2
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receptor (D2R) antagonist, sulpiride, and the CB1 receptor (CB1R) antagonist, AM251,
was used to pharmacologically isolate the neurotransmitter systems involved in the G  E
factors and interactions, since each of these neurotransmitter systems has been shown to
be essential for the induction of LTD in the cortico-striatal pathway (Surmeier et al.,
2007). Each set of experiments also used paired pulses separated by a 50 ms interpulse
interval (IPI) to assess changes in the paired pulse ratio (PPR) during induction of LTD
or STD as well as in the presence of a D2R or CB1R antagonist.
1a- Characterize G  E factors and interactions in synaptic depression (LTD
and STD) in the four G  E groups. The effect of G  E factors and interactions on
synaptic plasticity was determined using cluster analysis followed by two-way ANOVA
to determine STD or LTD induction. Each set of experiments also used paired pulses at a
50 ms IPI to assess changes in paired pulse ratio (PPR) during induction of LTD or STD.

1b- Characterize the effect of D2R antagonists in long-term synaptic
depression in the four G  E groups. These experiments used the same protocol as 1a
above, except that slices were pre-incubated for ~20 minutes in the D2R antagonist, 10
μM sulpiride, prior to the start of the experiment and sulpiride will be continually
perfused in the bath during the experiment. It was important to assess antagonism of
D2Rs because D2R activation has been demonstrated to be crucial for induction of LTD
in the striatum (Calabresi et al., 1992; Surmeier et al., 2007), and because preliminary in
vivo microdialysis data of HET/Sac mice showed that they were hyperdopaminergic,
which suggests that the dopamine system is affected by the Snap25 heterozygote
condition. Each set of experiments used paired pulses at a 50 ms IPI to assess changes in
paired pulse ratio (PPR) during induction of LTD or STD in the presence of the D2R
antagonist.

1c- Characterize the effect of CB1R antagonists in long-term synaptic
expression in the four G  E groups. These experiments used the same protocol as 1a
above, except that slices were preincubated for ~20 minutes in the CB1R antagonist, 2
μM AM251, prior to the start of the experiment and AM251 will be continually perfused
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in the bath during the experiment. It was important to assess antagonism of CB1Rs
because CB1Rs have been implicated as crucial for induction of LTD in the striatum
(Surmeier et al., 2007). Each set of experiments also used paired pulses at a 50 ms IPI to
assess changes in paired pulse ratio (PPR) during induction of LTD or STD in the
presence of the CB1R antagonist.

Aim 2-To characterize gene-environmental factors and interactions in striatal D2Rs
using a dopamine agonist-stimulated [35S]-GTP-γ-S binding assay to quantify changes
in D2R affinity, receptor coupling and number of receptors.
An agonist-stimulated [35S]-GTPγS binding assay was used to characterize
changes of the binding kinetics of D2Rs in the dorsal striatum in the four G  E
experimental groups. The method targets D2R G-protein coupled receptors (GPCRs) and
detects effects due to changes in affinity and/or receptor-effector coupling (Sovago et al.,
2001).

2a- Determine approximate EC50 and EC100 values using a dopamine agonist
stimulated [35S]-GTP-γ-S binding assay. Initial experiments were performed in
WT/Sac controls to determine approximate EC50 and EC100 values in order to calibrate
experiments performed on all four G  E groups.
2b- Characterize D2R changes produced by G  E factors and interactions using a
dopamine agonist stimulated [35S]-GTP-γ-S binding assay. These experiments
utilized previously determined EC50 and EC100 values (Aim 2a) in experiments to
compare agonist binding under each of the conditions. The [35S]-GTP-γ-S binding assay
is an indirect method in that it measures dopamine agonist stimulated GTP binding, so it
does not distinguish between agonist binding of GPCRs and effects due to coupling of
Gα proteins and downstream effectors.
Aim 3- To characterize G  E factors and interactions in striatal D2Rs using a [3H]quinpiriole dopamine agonist radioligand saturation binding assay to further quantify
changes in D2R affinity and number of receptors .
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As a follow up to Aim 2, a [3H]-quinpirole dopamine agonist radioligand
saturation binding assay and Scatchard analysis was used to determine if D2R affinity
(Kd) and maximum binding (Bmax) in the dorsal striatum are affected by G  E
interactions. These experiments were carried out with striatal brain homogenates
(Levant et al., 1992) using comparable sets of mice as described in Aims 1 and 2.
3a- Use saturation binding assays to determine the range of [3H]-quinpirole
dopamine agonist levels and verify the efficacy of the antagonist. These preliminary
experiments were carried out in WT/Sac controls to determine the proper ranges of D2R
agonists and appropriate concentrations of the D2R antagonist for the saturation
experiments.
3b- Determine changes in affinity and maximum binding produced by G  E factors
and interactions using a [3H]-quinpirole dopamine agonist radioligand saturation
binding assay. Based on preliminary values determined in aim 3a, these experiments
were used to determine if changes in D2R affinity (Kd) and maximum binding (Bmax) in
the dorsal striatum are affected by G  E factors. These experiments were carried out in
striatal brain homogenates and used Scatchard analysis of the resulting saturation binding
assays of the four G  E groups to determine Kd and the Bmax values.
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Chapter 3- Methods
The majority of the methods corresponding to the mouse breeding,
electrophysiology and binding studies are found in our recent publication (Baca et al.,
2013).

Mouse breeding and experimental design
All experiments were approved by the University of New Mexico Health Sciences
Center Laboratory Animal Care and Use Committees and the National Institutes of
Health. Mice used for all experiments were maintained in a 12 hour reverse light/dark
cycle; lights on at 8PM and lights off at 8AM.
A 2  2 design was developed to evaluate the interactions of genotype and
environment on cortico-striatal signaling and this design was used in all specific aims.
Snap25 heterozygote knockout male mice (HET) (Washbourne et al., 2002) were bred
with wild type C57BL/6J female mice (WT) under either saccharine bottle fed conditions
or prenatal nicotine exposure (PNE) bottle fed conditions during pregnancy according to
standard protocols (Paz et al., 2007) This design produced four experimental groups of
mice representing genotype (HET)  environmental (PNE) factors and interactions
designated as: WT/Sac, WT/PNE, HET/Sac and HET/PNE as illustrated in Fig. 3.1.
Wild type (WT) and heterozygous (HET) offspring were evaluated between 35-50
days of age (average ~PN 40 for each group, shown in Table 3.1) to model an adolescent
stage of brain maturation. No significant differences were found among the different
groups in weights of the mice at PN40.
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Wild type ♀ x Snap25 HET ♂
SNAP 25 hetero (HET/Sac)

C57BL/6 (WT/Sac - control)
Males
30-50 day
old
‘adolescent’
mice

(Gene –
HET/Sac)

Prenatal Nicotine
Exposure (PNE)

(EnvironmentWT/PNE)

(G X E –
HET/PNE)

Fig. 3.1: Experimental paradigm used to generate G  E groups in all experiments.

Group

Age (PN day)

Weight (g)

Male

Female

Male

Female

WT/Sac

40.2 ± 0.7

37.8 ± 0.4

20.5 ± 0.3

17.0 ± 0.3

WT/PNE

38.8 ± 0.6

39.1 ± 0.4

20.8 ± 0.3

18.2 ± 0.5

HET/Sac

39.6 ± 1.0

38.0 ± 0.4

19.9 ± 0.4

16.5 ± 0.3

HET/PNE

39.8 ± 0.5

39.5 ± 0.6

20.6 ± 0.3

17.1 ± 0.3

Table 3.1: Average age and weight of mice used in all experiments.
Males were used in electrophysiology and binding studies (n=24- 31 animals). Females were
3
used in addition to males (n=10 animals) only for [ H]-Quinpirole D2R agonist saturation binding
experiments. Values shown are mean ± SEM. No significant differences were found between
ages used or weights of mice in any of the experiments.
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Snap25 heterozygote mice
Heterozygous Snap25 deficient mice (referred to as HET/Sac or HET/PNE groups
depending on whether they were provided with drinking water containing saccharine or
nicotine as described below) (Washbourne et al., 2002) were maintained by brother/sister
heterozygote matings for 7 backcrossed generations to C57Bl/6 mice at the UNM HSC
Animal Resource Facility. The heterozygous Snap25 deficient mice, also referred to as
Snap25 haplodeficient mice are equipped with one wild type Snap25 gene and one null
Snap25 gene. SNAP-25 coding sequence was disrupted in the target construct by
replacing exon 5a and 5b with a PGK-neo gene cassette (Washbourne et al., 2002) to
generate the disrupted Snap25 gene as shown in Fig. 3.2. Genotyping was performed by
PCR as described previously (Washbourne et al., 2002) by tail clips taken after brains
were removed for electrophysiology and binding experiments as described below.

Fig. 3.2: Snap25 heterozygotes generated by knockout of Exon 5a/5b (Washbourne

et al., 2002).
Prenatal nicotine exposure
Mice were exposed prenatally to nicotine via drinking water as previously
described (Paz et al., 2007). In this paradigm, breeding pairs were provided either with
drinking water containing nicotine and saccharine (0.05 mg/ml and 0.6 mg/ml,
respectively; PNE) or saccharine alone (Sac) ad libitum prior to and throughout gestation.
To avoid potential effects due to an interaction between nicotine and a SNAP-25
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deficient intrauterine environment, wild type females and heterozygote Snap25 null
males were used as breeding pairs. The prenatal nicotine exposed (PNE) dams were
provided with 0.05 mg/ml nicotine and saccharine two weeks prior to pregnancy, during
pregnancy, while the saccharine control dams were provided with saccharine during the
same period (Paz et al., 2007). This nicotine dose corresponds to ~20 ng/ml in blood
plasma or approximately levels equivalent in humans to ~1 pack/day. Following birth, the
nicotine/saccharine content of the drinking water was gradually tapered down over one
week to standard drinking water to limit any possible effects on perinatal brain
development.

Slice preparation for electrophysiology
Electrophysiology experiments were performed in coronal striatal slices prepared
from 35-50 day old male mice using standard techniques (Schiess et al., 2006). Briefly,
animals were deeply anaesthetized by I.P. injection of 250 mg kg−1 ketamine, brains were
rapidly removed, and slices cut at 300 μm with a vibroslicer (Pelco 101, St Louis, MO,
USA) in an ice bath with a cutting solution containing (mM): 220 sucrose, 3 KCl, 1.2
NaH2PO4, 26 NaHCO3, 12 MgSO4, 0.2 CaCl2, 10 glucose and 0.01 mg ml−1 ketamine
equilibrated with 95%O2–5%CO2. Slices were then transferred to artificial cerebrospinal
fluid (ACSF) containing (mM): 126 NaCl, 3 KCl, 1.25 NaH2PO4, 1 MgSO4, 26 NaHCO3,
2 CaCl2 and 10 glucose equilibrated with 95%O2–5%CO2 at 30 °C for 1 h and then
maintained at room temperature until recording in a constant flow chamber (Warner
Instruments, Hamden, CT, USA or Scientific Systems Design, Mercerville, NJ, USA)
maintained at 32 °C and continuously perfused at 2 ml min−1 with ACSF saturated with
95%O2–5%CO2.

Population spike recordings
Standard electrophysiological techniques were used for field potential (fEPSP)
population spike (PS) recordings (Schiess et al., 2006) in the dorsal striatum
(approximately 0.5-1.0 mm from the corpus callosum (CC) border) following stimulation
of cortical layer V afferents (Fig. 3.3). The resulting PSs represent predominately
activity of medium spiny neurons (MSNs) (Surmeier et al., 1996). fEPSPs were recorded
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with an Axoclamp 2B (Molecular Devices, Sunnyvale, CA), amplifier and a Digidata
1322A interface using pCLAMP 9.2 software (Molecular Devices) for experimental
control and data analysis. Recordings were digitized at 500 kHz and filtered at 2 kHz.

Fig. 3.3: Illustration of stimulation and recording of population spikes of MSNs in
the dorsal striatum.

PS amplitudes were calculated by subtracting the average of the peak of the two
positive phases (RP1 and RP2) of the fEPSP from the maximum intervening negative
spike as shown in the example population spike on the left side of Fig. 3.5. Paired presynaptic constant current pulses (150 μs duration) with a 50 ms interpulse interval were
applied at 20 second intervals with an Iso-Flex constant current stimulator (API
Instruments, Jerusalem, Israel) through a concentric bipolar electrode (FHC,
Bowdoinham, ME, USA). Test (~1/2 maximum) or HFS (~maximum) stimulus
intensities were determined from an input-output curve. An example input-output curve
showing the amplitude of the PS plotted as a function of the stimulus current amplitude is
shown in Fig. 3.4.
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Fig. 3.4: Example input-output curve used to determine current inputs associated
with half maximum and maximum population spike amplitudes.

To assess long-term synaptic plasticity in the cortico-striatal field, a 10 minute
baseline was established at ½ maximum (test) stimulus intensity, then a high frequency
(HFS) paradigm consisting of 4 sets of 1 s 100 Hz pulses at the maximum intensity was
applied, and finally 30 minutes of recordings were obtained again at ½ maximum
stimulus intensity to determine the time course of the effect of the HFS. The efficacy of
alternative paradigms on their ability to induce long-term plasticity is discussed in
Appendix 2. The average amplitude of the final 10 PSs of the 30 minute recovery period
following the HFS (results- R) was compared to the average amplitude of 32 PSs during
the 10 minute pre-HFS baseline (B) in order to determine the percentage of change
relative to the baseline (R/B). Fig. 3.5 shows that for a given experiment, immediately
following HFS, the PS amplitude typically decreased to ~20% of the baseline amplitude.
During the subsequent 30 minute recovery period, the PS either returned substantially
back to baseline (designated as short-term depression (STD)) or remained attenuated
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(designated as long-term depression (LTD)) as illustrated in Fig. 3.5. Cluster analysis, as
described below, was used to designate which results were classified as STD or LTD.
Cluster analysis also provided the mean and standard error of the mean for the 30 minute
recovery values of the PS amplitude as a function of the baseline levels for the STD,
LTD, and total clusters.

30 minutes later
RESULTS
population spikes

10 minute BASELINE
population spikes

90%

STD

average = 100% pop spike baseline
RP1

RP2

Test Stimulus
(1/2 max)
=100%

100 Hz
High
frequency
stimulus
(1sec, 4X)

20%

OR

t=40 min

HFS
(max)

Neg. Spike

t=0 min

t=10 min
25%

LTD

STD = short term depression
LTD = long term depression

Fig. 3.5: Illustration of the HFS paradigm used in electrophysiology recordings and
distinction between STD and LTD as determined by cluster analysis.

As described above, each electrophysiology experiment involved recordings of
PSs in response to paired pulses at 50 ms interpulse interval recorded during the baseline
(B), HFS, and during the results (R) following HFS. This allowed a comparison of the
paired pulse ratio (PPR) calculated as the ratio of the second population spike (R2)
amplitude to the first population spike (R1) amplitude. When the R2 PS amplitude is
greater than the R1 PS amplitude this is designated as paired pulse facilitation (PPF).
When the R2 PS amplitude is less than the R1 PS amplitude, this is designated as paired
pulse depression (PPD). Example population spikes showing PPF and PPD are shown in
Fig. 3.6. Because the PPR has been used as a measure of the probability of pre-synaptic
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release, these measurements provide potentially useful information about pre-synaptic
effects of the HFS protocol.

R1

PPF

R2

R1

PPD

R2

0.5 mV
5 ms

Fig. 3.6: Example of 50 ms interpulse interval recordings showing PPF (top)
and PPD (bottom).
For each of the four experimental groups, receptor antagonist experiments were
carried out in which the D2 receptor antagonist 10 μM sulpiride or the CB1 receptor
antagonist 2 μM AM251 were added to the ACSF bath in order to examine the
contribution these receptors to the establishment or maintenance of long-term synaptic
depression. Slices were pretreated in the drug for 20 minutes prior to the start of each
experiment and for the duration of each experiment. Other than the addition of receptor
antagonists, the same field recordings and HFS paradigm were used for each
experimental group as the experiments without receptor antagonists. A minimum of 6
slices was recorded in the experiment for each condition both for drug and non-drug
perfused experiments.
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The time course of recovery was determined for the STD populations, as well as
for experiments in the presence of a CB1R and D2R antagonists for all experimental
groups. First, from the average values of each set of experiments, an exponential least
squares regression fit was made from the initial ~20% depression of the PS to the final
value of the PS after 30 minutes. The data were then fit with a least squares regression to
the equation:


Where: Y = value of the PS as a percentage of the baseline PS (normalized to
100%); B = initial value of PS after HFS; A= final value of PS 30 minutes after HFS; t =
time (minutes);  = time constant representing time necessary to decay to 1/e of final
value of PS

This equation models an exponential decay to a final recovered value following
HFS. The time constant () measures the relative rate of recovery in minutes for STD,
allowing comparison of recovery rates among the experimental groups. After fitting, the
data were inverted by subtracting the final estimated value A (estimated recovery after 30
minutes) from each point so that the initial PS following HFS becomes the largest value
and the final value after 30 minutes becomes the smallest. Finally the y axis representing
the inverse of the PS value (recovery - PS) at each time point is plotted in a logarithmic
scale to display regression plots as linear where the time constant is now -1/slope of each
curve.
Dopamine agonist stimulated [35S]-GTP-γ-S binding assay
[35S]-GTP-γ-S binding assays were conducted by a method described previously
(Martinez et al., 2008). Brains were removed from 35-50 day old male mice from each
of the four experimental groups and immediately immersed in isopentane at -35 °C,
chilled in a dry ice/methanol bath and then stored in airtight containers at −80 °C until
sectioning. Coronal sections (10 m) that included the striatum (approximately from
Bregma 0.98 to -0.94) were cut and the level of sectioning in each plane was verified by
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examination of Nissl-stained sections. Sections were thaw-mounted onto pre-cleaned
Superfrost- Plus® microscope slides (VWR Scientific, West Chester, PA) and stored at
−80 °C in airtight containers until assays were performed.
Slides were pre-incubated in assay buffer (50 mM Tris-HCl, 100 mM NaCl, 5
mM MgCl2, pH 7.4 at 25 °C) containing 1 mM DL dithiothreitol, 0.2 mM EGTA and 2
mM GDP at 25 °C for 10 min. Sections were then incubated with 100 pM [35S]-GTPγS
(specific activity = 1250 Ci/mmole; Perkin Elmer Life Sciences, Boston, MA) for 90
minutes in the absence or presence of 10 μM unlabeled GTPγS and D2R agonist,
quinelorane. After incubation, sections were rinsed twice for 15 seconds each in fresh
incubation buffer at 4 °C, dipped for one second in 4 °C distilled water, dried under a
stream of cool air, and then vacuum desiccated overnight. Autoradiograms (Biomax MR
Film) were produced with a set of 14C standards following a 4 day exposure.
Microdensitometry of ligand binding in the striatum was performed using Media
Cybernetics Image Pro Plus® (Silver Spring, MD) on an Olympus BH-2 microscope at a
total image magnification of 3.125. In each assay, an optical density standard curve,
expressed in picoCuries/105 μm2, was established based on the autoradiograms of the
standards.
The approximate EC50 determined for quinelorane-stimulated [35S]-GTPγS
binding was 20 μM and the EC100 was 200 μM based upon preliminary experiments
carried out across a range of agonist values in WT/Sac control mice as presented in the
Results. As a control, 50 μM sulpiride was used as an antagonist to a 100 μM
quinelorane concentration and found to fully block the response as described in the
Results.
Total [35S]-GTPγS binding in the left and right paired sections from each brain
region of interest was measured in quadruplicate sections incubated with varying levels
of quinelorane. Non-specific [35S]-GTPγS binding was measured in duplicate sections
incubated with the addition of 10 μM excess unlabeled GTPγS with varying levels of
quinelorane. Total binding and non-specific binding were both determined by subtracting
the background binding from each autoradiogram. The specific binding was then
determined by subtracting total binding (average of quadruplicate sections for each n)
from non-specific binding (average of duplicate sections for each n). This is illustrated in
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Fig 3.7, which shows an example of total binding in an autoradiogram of a coronal slice
in the presence of a saturating concentration of agonist. Not shown is an autoradiograph
of a non-specific binding slice, which is subtracted from total binding to determine
specific binding.
The preliminary results for WT/Sac controls were fitted to a Hill equation
(Goutelle et al., 2008; Heck, 1971) as shown below to obtain the dissociation constant Kd
associated with the EC50 agonist binding levels for a half maximum response to the
agonist. The dissociation constant Kd was used to calibrate the EC50 agonist level selected
for the experiment. Values close to maximum responses in the preliminary experiments
were used to calibrate the EC100 agonist level selected for the experiment.
Hill Equation:

Where: [B] = concentration of ligand (agonist) bound to the receptor (µM); [L] =
concentration of free ligand (agonist) (µM); Bmax = maximum response to agonist
(femtomoles/ 105 µm2); Kd = dissociation constant (µM), n = Hill coefficient

Specific binding = (total binding

–

total - background

non specific binding)
non-spec - background

Fig. 3.7: Example autoradiogram of a coronal striatal brain slice illustrating how
specific binding levels are calculated. Averages of total binding (in quadruplicate sections)
with background binding subtracted (shown) are subtracted from averages of non-specific
binding slices (in duplicate sections) with background binding subtracted (non-shown).
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Quinelorane-stimulated [35S]-GTPγS binding was measured to compare basal
binding (without quinelorane), and net binding for both the EC50 (20 μM) and EC100 (200
μM) quinelorane concentrations as determined by preliminary experiments with WT/Sac
controls. The net binding was determined by subtracting the basal binding values from
the EC50 (20 μM) and EC100 (200 μM) binding values to obtain net binding values for the
EC50 (20 μM) and EC100 (200 μM) quinelorane concentrations. The use of net binding
permitted quantification of quinelorane binding at each agonist concentration (EC50 and
EC100) in order to determine the differential effects of the agonist-stimulated responses on
GTP binding. Each n for each experimental group included quadruplicate coronal
sections each for basal, EC50, and EC100 quinelorane levels as well as duplicate coronal
sections for non-specific binding including 10 μM unlabeled GTPγS. A total of n = 6 was
used for each experimental group.
[3H]-Quinpirole dopamine agonist radioligand saturation binding assay
Saturation binding assays were conducted by methods described previously
(Levant et al., 1992). Brains were removed from 35 – 50 day old mice and immediately
immersed in isopentane at -35 °C, chilled in a dry ice/methanol bath and then stored in
airtight containers at -80 °C until homogenation. Each brain homogenate consisted of 4
total brains (2 male and 2 female) in order to obtain sufficient tissue. Brain tissue was
homogenized in 20 volumes of assay buffer (50 mM Tris-HCl, 5 mM KCl, 2 mM MgCl2,
and 2 mM CaCl2, pH 7.4) at 23 °C using fitted spherical glass homogenizers. The crude
homogenate was centrifuged twice for 30 and 15 minutes respectively at 13,000  g, to
yield a final tissue concentration of 1.5 - 2.5 mg per ml buffer. Brain protein levels were
quantified by Bradford assays and refrozen until binding assays were performed.
Saturation binding assays were performed in triplicate polystyrene tubes in a final
volume of 0.3 ml of assay buffer as described (Levant et al., 1992). The dopamine
agonist, [3H]-quinpirole, was included at 6 concentrations ~0.2 nM to ~9 nM as
determined from preliminary binding studies as presented in the Results (Levant et al.,
1992). Binding was initiated by the addition of membrane homogenate at room
temperature and maintained for 5 hours to allow saturation to occur. Non-specific
binding was defined in the presence of 50 μM spiperone. The reaction was terminated by

42

the separation of the free from bound radioligand by rapid filtration over Whatman GF/B
filters using a Brandel cell harvester. Filters were washed twice with 3 ml of ice-cold 50
mM tris-HCl, pH 8.0 and punched into mini-vials. After the addition of the scintillation
cocktail (Packard Ultima Gold), vials were shaken, allowed to equilibrate for at least 5
hours, and counted in a Packard model 2000 liquid scintillation counter. Kd and Bmax
were determined for [3H]-quinpirole from least squares fits to Scatchard plots of triplicate
samples using data from the specific and non-specific binding from 5 samples (brain
homogenates) of the four experimental groups as presented in the Results as well as
Appendix 1.

Drugs
The following drugs were stored frozen in aliquots and diluted to the appropriate
concentration in ACSF for electrophysiology or pharmacological assay on the day of the
experiment. S-sulpiride, AM251, quinelorane, dithiothreitol and spiperone were obtained
from Tocris (Ellisville, MO, USA); GDP and GTPγS from Sigma-Aldrich (St Louis, MO,
USA); [35S]-GTPγS and [3H]-quinpirole from Perkin-Elmer (Waltham, MA, USA).
Aliquots of S-sulpiride were made in DMSO as required.

Data analysis
SPSS 16.0 (SPSS, Inc., Chicago, IL) was used for statistical analysis of data.
Numerical values for data measurements are expressed as the mean ± standard error
unless otherwise specified. Statistical p values were represented as follows: * p < 0.05;
** p < 0.01 and *** p<0.001. The paradigm used for the electrophysiology and binding
experiments was designed as a 2  2 analysis to compare effects of genotype and
environment. Comparisons were made with a two-way ANOVA two genotype (HET v
WT)  two prenatal treatment (PNE v Sac) groups and all post-hoc tests were Tukey’s
HSD unless otherwise noted.
A two-step cluster analysis with no pre-determined number of clusters (SPSS
16.0) was used to group the field potential experiments into STD and LTD clusters for
each experimental group (Fig. 3.5). The two-step cluster analysis utilizes a Student’s ttest with a Bonferroni adjustment applied to statistically discriminate clusters. An
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example of the cluster analysis is shown in the Results. This analysis seeks to identify
clusters within a data set that minimize within-group variation and maximize betweengroup variation. The result of the cluster analysis is the identification of either a single
cluster or several (2 or more) clusters within the data set as well as the mean and standard
deviation for each identified cluster.

44

Chapter 4 - Results
Overall hypothesis and approach
To reiterate, the hypothesis of this research is that G  E factors and interactions
from the Snap25 haplodeficiency and prenatal nicotine exposure lead to long term
impairments in D2 receptor functionality in striatal medium spiny neurons. This occurs as
a result of impairments of D2 receptor affinity and signaling leading to impairments of
the process of striatal LTD induction. Snap25 heterozygote knockout male mice (HET)
were bred with wild type C57BL/6J female mice (WT) under either saccharine or
prenatal nicotine exposure (PNE) bottle fed conditions during pregnancy to produce four
experimental groups of mice representing genotype (HET)  environmental (PNE)
interactions designated as: WT/Sac, WT/PNE, HET/Sac and HET/PNE as further
described in the Methods. Changes in synaptic plasticity were explored by comparing the
induction of LTD in these four G  E experimental groups as described below. The
results related both to the electrophysiology and binding studies presented here have been
recently published (Baca et al., 2013). All methods used including the statistics described
below for cluster analysis, ANOVA, and post-hoc tests, unless noted otherwise, are
presented in the Methods. The results of this research are presented in order of the
specific aims as outlined in the Hypothesis chapter:
Aim 1-To characterize G  E factors and interactions in long-term synaptic depression
using a high frequency stimulus (HFS) LTD induction paradigm.
Aim 2-To characterize G  E factors and interactions in striatal D2Rs using a dopamine
agonist-stimulated [35S]-GTP-γ-S binding assay.
Aim 3- To characterize G  E factors and interactions in striatal D2Rs using a [3H]quinpirole dopamine agonist radioligand saturation binding assay.

45

D2R-dependent induction of long-term synaptic depression (LTD) in the striatum is
affected by HET genotype and PNE treatment and their interactions
To characterize use-dependent plasticity in these preparations, I used a high
frequency stimulus (HFS) paradigm to elicit synaptic depression of cortical inputs to the
dorsal striatum in coronal slices of the WT/Sac control group (Calabresi et al., 1992;
Lovinger et al., 1993). This paradigm was selected because it is the most common
paradigm used in the literature to elucidate the mechanisms involved in the induction of
LTD thereby allowing the results to be compared with a body of existing literature
(Kreitzer and Malenka, 2008; Lovinger, 2010; Surmeier et al., 2007). A series of
preliminary experiments independent of this research were performed to explore how
different frequency paradigms may affect the induction of LTD. A summary of these
results are presented in Appendix 2. As described in more detail in the Methods, for each
slice I determined the input stimulus intensity necessary to produce a half maximum
amplitude PS for use during baseline and recovery periods and maximum amplitude PS
for the HFS induction protocol. The amplitude of the PS 30 minutes after HFS was then
compared to the average amplitude during the 10 minute baseline period to determine the
percentage recovery to baseline for each slice following HFS (see Methods; Figure 3.5).
Following the HFS stimulus, all slices exhibited an initial depression in the PS
amplitude to ~20% of baseline (post-tetanic depression, PTD). For some slices, the PS
returned to near baseline within a few minutes, while for other slices the PS remained
depressed for the full 30 minute recording period. I used a cluster analysis (see Methods)
to make an unbiased differentiation between the two populations of responses that were
then defined operationally as short-term depression (STD) and long-term depression
(LTD) based on the percent of PS recovery at 30 minutes. Fig. 4.1A shows
representative PS records from slices of the designated STD and LTD clusters that were
measured during baseline recording and then 30 minutes after HFS. Fig 4.1B provides a
comparison of the PS recoveries of the STD and LTD populations as well as the
combined data for all slices recorded in the WT/Sac group. Fig 4.1C shows the time
course for the STD, LTD, and combined populations and includes the 10 minute baseline
and 30 minute recovery period following HFS for each population. Further analysis of the
data of the percent PS amplitude recovery following HFS for LTD and STD populations
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(Fig 4.1B and 4.1C) indicate that ~40% (6/15) of the slices were included in the LTD
cluster and the remaining ~60% (9/15) of the slices were included the STD cluster. The
observation that the HFS paradigm can result in STD, as well as LTD, has been reported
previously (Lovinger et al., 1993; Sung et al., 2001) and suggests that, since both
processes can result from HFS, they may be interrelated. One possible relationship is that
PTD induces STD, which in turn can be transformed into LTD. The relationship between
STD and LTD will be explored further in the Discussion.
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Fig. 4.1: Cluster analysis determination of STD and LTD populations in WT/Sac
control group. A Representative population spike (PS) traces of STD and LTD for baseline
(gray) and 30 minutes after HFS (black). B Comparison of percent recovery of PS at 30 minutes
after HFS for LTD and STD clusters as well as the combined results without clustering showed
significantly distinct STD and LTD clusters, (p<0.01). C Long-term synaptic plasticity in
WT/Sac control group was induced with HFS (4  100 Hz, 1 s) producing either LTD (<30%
recovery at 40 min, black □) or STD (>70% recovery at 40 min, white ○) as determined by cluster
analysis. Combined results (gray ∆) before cluster analysis are also shown. PS amplitude was
normalized to initial 10 minute baseline preceding HFS. STD samples n = 9 slices; LTD samples
n= 6 slices; values shown as mean ± SEM.

As described above, I utilized a HFS paradigm in which the test stimulus applied
during the 10 minute baseline and 30 minute recovery periods was adjusted to produce a
half maximum PS amplitude while that during the HFS stimulus was set to produce a
maximum PS amplitude. I next tested whether varying the test stimulus intensity had any
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effect on the propensity to produce STD or LTD in the WT/Sac group. Varying this
intensity from ~0.35 to 0.70 of the maximum, tended to produce an increase in the final
PS amplitude at 30 minutes of recovery (Fig. 4.2). However, the correlation was weak (r2
= 0.1007; n=13) and the 95% confidence interval was between -78% and 238%,
indicating no clear effect of test stimulus amplitude on the induction of LTD or STD. For
this reason, I maintained the baseline and recovery period stimulus amplitude at the value
necessary to generate ½ maximum PS amplitude for the remaining experiments including
those involving the other experimental groups (WT/PNE, HET/Sac, and HET/PNE).
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Fig. 4.2: Effect of variation of the ratio of test and HFS input stimulus on final
population spike magnitudes in WT/Sac control group. Using the same HFS paradigm, the
ratio of the test stimulus PS applied during the baseline and 30 minute post-HFS versus the HFS
PS was varied from ~0.3 – 0.7 (nominally set at ~0.5). There was a weak positive correlation for
a linear regression of %PS amplitude vs. test stimulus amplitude (r2 = 0.1007) with increased
test/HFS input ratio to final pop spike amplitude.

I next assessed whether the induction of these two forms of synaptic plasticity
differed among the remaining experimental groups (WT/PNE, HET/Sac, and HET/PNE).
HFS in slices prepared from each of these three groups produced responses that were
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qualitatively similar to those seen in the WT/Sac control group and could be resolved by
cluster analysis into LTD (Fig. 4.3A, B) or STD (Fig. 4.3C, D) clusters that were
significantly different from each other (Fig. 4.4 A, B, C & D, p < 0.01).
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Fig. 4.3: Comparison of STD and LTD between the four G  E groups. A, C Time
course of PS amplitude normalized to initial 10 minute baseline following HFS in LTD (A) and
STD (C) populations of the four G  E experimental groups. (mean ± SEM, STD n = 5- 9 slices;
LTD n= 6- 8 slices) (WT/Sac, black ○; WT/PNE, green □; HET/Sac, blue ∆; HET/PNE, red ◊).
B, D Percent recovery of PS at 30 minutes following HFS in LTD (B) and STD (D) clusters
shown in A and C for the four G E experimental groups. Post-hoc tests for LTD group revealed
that WT/Sac group showed significantly greater maintained depression than HET/Sac and
HET/PNE groups (p < 0.01).
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A two-way ANOVA comparing the levels of LTD revealed a significant effect of
genotype (F(1,22)=23.81, p < 0.001), as well as a significant interaction of genotype 
treatment (F(1,22)=12.42, p < 0.01), but not of treatment alone (F(1,22)=0.20, p=0.66). A
post-hoc test of the comparisons between LTD populations showed that the HET/PNE
and HET/Sac groups exhibited less robust LTD (~1.7 – 2.2 fold larger PS after 30
minutes) compared to the WT/Sac control group (Fig. 4.3A, B; p<0.01) indicating
reduced LTD in the HET mice regardless of prenatal exposure. The WT/PNE group also
displayed less robust LTD approaching significance in comparison to the WT/Sac group
(p=0.057).
In contrast, two-way ANOVA of the levels of STD (% PS recovered after 30
minutes) revealed a significant effect of treatment (F(1,27)=5.16, p < 0.05), but not
genotype (F(1,27)=1.13, p = 0.30), or genotype  treatment (F(1,27)=2.26, p = 0.14). While
the STD obtained from slices of the HET/PNE group showed less recovery to baseline,
~0.7 – 0.8 fold compared to the other groups, this decrease was not significant after posthoc analysis (Fig. 4.3C, D).
A further comparison of the relative level of LTD to that of STD obtained for
each group (% PSSTD / % PSLTD) revealed that the ~1.7 fold difference between STD and
LTD in the HET/PNE group (Fig. 4.4D) was less; than that found for the other groups
(WT/Sac ~3.9 fold, Fig. 4.4A; WT/PNE ~2.4 fold, Fig. 4.4B; HET/Sac ~1.9 fold; Fig.
4.4C). Additionally, a larger percentage of slices in the HET/PNE group underwent LTD
rather than STD (~62%, 8/13) (WT/Sac ~40%, 6/15; WT/PNE ~40%, 6/15; HET/Sac
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~43%; 6/14). These results indicate a selective alteration in the mechanisms responsible
for initiating the transition from STD to LTD in the HET/PNE group.
I made an additional assessment of the differences in the stimulus intensity
necessary to evoke similar PS amplitudes in the four groups to determine whether there
were differences in intrinsic excitability between groups. Comparisons were made of the
ratio of the amplitudes of the PS produced to the half maximum input stimulus for each
group during baseline recordings prior to HFS inputs (Fig. 3.4, Methods; PS output in
mV divided by test input stimulus (1/2 maximum) in mA). The values found for each
group were WT/Sac 1.096 ± 0.136; WT/PNE 1.044 ± 0.145; HET/Sac 1.102 ± 0.093;
HET/PNE 1.132 ± 0.109 (magnitude (mV/mA) ± SE; n=7 slices per group). A two-way
ANOVA comparing the responses between these groups showed no significant effects for
genotype (F(1,24)= 0.15, p =0.71), treatment (F(1,24)=0.08, p =0.93), or interaction of
genotype  treatment (F(1,24)=0.11, p =0.74). This indicates that the differences in relative
amounts of LTD and STD were not due to changes in excitability of afferent inputs to
MSNs, since the relative size of PS produced for each was not significantly different.
Both CB1 and D2 receptors, along with other receptors including metabotropic
glutamate receptors (mGluRs), have been shown to be critical in the process of induction
of LTD in cortico-striatal synapses (Kreitzer and Malenka, 2005; Surmeier et al., 2007).
Therefore, because of the differences that were found between the HET/PNE and other
groups, both in terms of eliciting either LTD or STD and in the levels of recovery of LTD
and STD, I tested whether the mechanisms responsible for induction of LTD were
affected by either the Snap25 genotype or PNE treatment. For these experiments, I used
the antagonists AM251 (2 μM) to block cannabinoid CB1Rs and sulpiride (10 μM) to
block dopamine D2Rs in each of the four G  E groups, using the same HFS paradigm
that produced distinct STD and LTD clusters (Fig. 4.3). As shown in Fig. 4.5A, cluster
analysis of data obtained for the WT/Sac control group in the presence of both CB1R and
D2R antagonists yielded only a single population that was similar in time course and final
value 30 minutes after HFS stimulus to our previously defined STD population,
consistent with previous studies suggesting that the transition from STD to LTD requires
both CB1Rs and D2Rs (Lovinger, 2010). Similarly, when I applied CB1R or D2R
antagonists in the WT/PNE, HET/Sac, and HET/PNE groups, I again observed a single
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cluster that was similar to the STD population (Fig. 4.5B, C, & D). Fig. 4.6 shows a
comparison of responses to CB1 and D2R antagonists within each group instead of
between groups as shown in Fig. 4.5 B and D. This suggests that activation of CB1R and
D2R pathways remain important for induction of LTD in WT/PNE, HET/Sac, and
HET/PNE groups.
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Fig. 4.5: Comparison of effects of D2R and CB1R antagonists on LTD induction
between the four G  E groups. A, C Time course of PS amplitude normalized to initial 10
minute baseline following HFS in the presence of CB1R antagonist, AM251, (2 μM) (A) and
D2R antagonist, sulpiride, (10 μM) (C) for the four G  E experimental groups. D2R antagonist
n = 6- 8 slices; CB1 antagonist n = 6- 7 slices; values shown are mean ± SEM. (WT/Sac, black ○;
WT/PNE, green □; HET/Sac, blue ∆; HET/PNE, red ◊). B, D Percent recovery of PS at 30
minutes following HFS in the presence of AM251 (B) and sulpiride (D) shown in A and C for the
four G E experimental groups. Post-hoc tests for D2R antagonists revealed HET/PNE group
significantly less recovery than other groups (p < 0.01).
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I next compared the response of the four G  E groups to HFS in the presence of a
CB1R antagonist. A two-way ANOVA comparing the response to HFS between these
groups in the presence of the CB1R antagonist did not reveal any significant differences
(Fig. 4.5 A, B), in keeping with the well-established central role of endocannabinoid
feedback in the induction of LTD (Adermark et al., 2009; Lovinger, 2010). This finding
suggests that the CB1R-dependent signaling pathway responsible for initiating LTD
induction is not impaired in HET mice exposed to prenatal nicotine.
I next compared the response of the four G  E groups to HFS in the presence of
the D2R antagonist. In contrast to the CB1R antagonist, a two-way ANOVA comparing
the response between these groups in the presence of the D2R antagonist revealed a
significant effect of genotype (F(1,23)=10.07, p < 0.01), treatment (F(1,23)=5.71, p < 0.05),
as well as a significant interaction of genotype  treatment (F(1,23)=5.97, p < 0.05). Posthoc analysis showed that the response of the HET/PNE group in the presence of the D2R
antagonist was significantly different from that of the other groups exhibiting decreased
recovery (~0.6 – 0.7 fold) (Fig. 5.5 C, D; p < 0.01). This finding strongly suggests that
the D2R-dependent signaling involved in LTD induction is selectively impaired in HET
mice exposed to prenatal nicotine.
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Differences in recovery rates of STD between groups with CB1R and D2R
antagonists
As discussed above, I found that following the HFS stimulus, the PS amplitude in
all slices exhibited an initial depression to ~20% of baseline (post-tetanic depression,
PTD). With the STD population, but not the LTD population, as determined by cluster
analysis, the PS amplitude returned to near baseline within a few minutes for all four G 
E groups. Similarly, application of CB1R or D2R antagonists in the four G  E groups,
produced a single response that was similar to the STD population response. I performed
additional analysis to compare the relative rates of recovery during STD between groups,
and in the presence of CB1R and D2R antagonists using the data shown in Fig. 4.3C for
STD and in Fig 4.5A & C for CB1R and D2R antagonists. I measured the recovery rate
by determining the least squares fit for the exponential recovery during STD following
the ~20% depression during PTD in the presence of CB1R and D2R antagonists for the
four G  E groups, and using the time constant () as a measure of the relative recovery
rate for each group. Fig. 4.7A illustrates the method for determining the time constant for
STD for the WT/Sac group (see Methods for details) and the same procedure was
repeated for the other groups, and in the presence of CB1R and D2R antagonists. Briefly
the time constant of recovery was determined as the negative slope of a least squares
regression fit to a plot of the 30 minute recovery period. The data was transformed to
display the difference between the maximum recovery fit of the PS after 30 minutes and
the value of each point, shown as a semilog plot versus time so the plots would be linear.
The time constant represents the time required for 1/e (37.8%) recovery to its final value.
I initially attempted to determine values from individual experiments and then
determine the mean and standard error in order compare groups. Unfortunately the decay
in some experiments did not follow a clear exponential and there was high variation in
many of the other experiments, and thus statistical analysis of these results could not be
performed. So I compared the average responses from each experiment for each group
(data taken from plots for STD; Fig. 4.3C; CB1 antagonist, Fig. 4.5A, D2 Antagonist,
Fig. 4.5 C). By using averaged responses, however, I was able to obtain exponential
decays from averaged values for each set of experiments for each of the groups.
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The WT/Sac group had a shorter time constant for STD than the other groups
(Fig. 4.7B: WT/Sac  = 5.4 min, WT/PNE  = 9.7 min, HET/Sac  = 8.4 min, HET/PNE
 = 9.1 min), showing that, although there may not be significant differences in the
fraction of slices in the STD cluster between groups, there was a small increase in the
time course of recovery as a result of the G  E factors and interactions. In the presence
of D2R antagonists there were no distinct differences between groups (Fig. 4.7C: WT/Sac
 = 6.3 min, WT/PNE  = 6.4 min, HET/Sac  = 7.1 min, HET/PNE  = 6.6 min), so
although D2R antagonists affect the magnitude of the final recovery after 30 minutes in
the HET/PNE group (Fig. 4.5D), they appear not to alter the time course of recovery. In
the presence of CB1 antagonists, there was a surprising increase in the time course of
recovery for the HET/PNE group compared to other groups (Fig. 4.7C: WT/Sac  = 5.3
min, WT/PNE  = 5.3 min, HET/Sac  = 5.1 min, HET/PNE  = 16.3 min), although, as
discussed previously, this did not manifest in any effects in the final recovery after 30
minutes in the HET/PNE group (Fig. 4.5B). The possible implications of these findings
are explored in the Discussion.
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Fig. 4.7: Least square regression analysis of recovery rates in the four G  E
groups for LTD induction paradigm for STD, or in the presence of a D2 antagonist
and CB1 antagonist. A Example least squares regression analysis of the average time
course for WT/Sac group (normalized to initial 10 minute baseline) for the 30 minute
recovery of the STD cluster following HFS (mean ± SEM, gray ○, n= 9 slices; regression
black line). Inset shows the least squares fit of the same data transformed with final fit
value for recovery (e.g. 95%) subtracted from each point, plotted over time in order to
obtain a linear plot with the slope represented as -1/, plotted as a semilog (final
recovered value subtracted from each point) versus time. Tau () represents the
exponential time constant necessary for 37.8% (1/e) of the final recovery after 30 minutes
from the initial drop following HFS. B-D Least square regression fits for LTD induction
experiments for the STD cluster, and in the presence of a D2 antagonist, and CB1
antagonist in the four G  E groups. As with the inset in Fig 4.7A, regression fit is
redrawn to show data with a negative slope (final fit recovery value subtracted from each
data point plotted over time). (Legend shows colors associated with each G  E
group).The WT/Sac group had a shorter time constant than other groups in STD
regression. All groups had similar time constants in the presence of a D2 antagonist. The
HET/PNE group had a longer time constant than other groups in the presence of a CB1
antagonist.
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Induction of long-term synaptic depression (LTD) in the striatum does not affect
paired pulse facilitation (PPF)
All of the above experiments were carried out with a pair of stimulus pulses
separated by a 50 ms interpulse interval (see Methods for details). As discussed in the
introduction, the paired pulse ratio (PPR), defined as the ratio of the PS amplitude of the
second pulse (R2) to that of the first (R1), is often used as an indication of pre-synaptic
contributions to a process. A ratio greater than 1 indicates paired pulse facilitation (PPF)
and less than 1 indicates paired pulse depression (PPD). PPF, in particular, is generally
considered to be a pre-synaptic process. I measured the PPR during the 10 minute
baseline period for each experiment as well as 30 minutes after the recovery period for
the four G  E groups and these results are displayed in Fig. 4.8. For the WT/Sac group,
the PPR did not change significantly between the baseline and recovery periods in the
STD and LTD populations, or in the presence of D2R or CB1R antagonists. Similarly
comparison of baseline and recovery periods for the other G  E groups did not reveal
significant differences in PPR between the STD and LTD populations, nor was it affected
by the presence of D2R or CB1R antagonists. A two-way ANOVA comparing PPR
between the G  E groups, between STD and LTD or in the presence of a CB1R or D2R
antagonist did not show a significant effect of genotype, treatment, or a significant
interaction of genotype  treatment. These results indicate that neither the HFS protocol
nor the various conditions that alter D2R signaling significantly alter the PPR. A net
increase in PPR (PPF) would imply a relative decrease in the probability of release of
pre-synaptic vesicles from cortical afferents onto MSNs. This suggests that these effects
on D2R signaling may not involve primarily a change in pre-synaptic glutamate release,
but rather that of post-synaptic changes in how D2Rs affect the induction of LTD.
Interestingly, these G  E changes appear not to involve the well-established pre-synaptic
role of long-term decreases in glutamate release involved in LTD induction (Choi and
Lovinger, 1997b). These implications will are explored further in the Discussion.
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Fig. 4.8: Comparison of effects of the paired pulse ratio on LTD induction in the
four G  E groups for STD and LTD clusters and in the presence of a CB1 or D2
antagonist. Paired pulses with a 50ms interpulse interval were recorded during the 10 minute
baseline and for 30 minutes following HFS for each experiment. The paired pulse ratio (PPR) of
the PS amplitude associated with the second stimulus (R2) divided by the PS amplitude
associated with the first stimulus (R1) or (R2/R1) was determined for the average of the 10
minute baseline period (B) and results 30 minutes after HFS (R). A Comparison of PPRs of
baseline (B) and 30 minute after HFS results (R) for LTD and STD clusters for the four G  E
groups revealed no differences in PPR between B and R within each group or comparisons
between groups (students t-test). B Comparison of PPRs of baseline (B) and 30 minute after HFS
results (R) for experiments in the presence of a CB1 or D2 antagonist for the four G  E groups
revealed no differences in PPR between B and R within each group or between groups (students
t-test).

I next examined PPR during the baseline period for each of the four G  E groups
for all experiments regardless of whether the HFS eventually produced LTD or STD or
whether the experiments were performed in the presence of a D2R or CB1R antagonist. I
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reasoned that these initial PPRs would not be a function of whether HFS led to LTD or
STD or the eventual effect of D2R or CB1R antagonists. The latter is justified by
published accounts, which indicate that CB1R and D2R antagonists primarily function in
the LTD induction process rather than during basal stimulus of MSNs (Centonze et al.,
2001; Singla et al., 2007). I performed cluster analysis on the baseline responses for each
of the four G  E groups and discovered that baseline PPR led to two clusters of slices:
~1/3 of the slices (WT/Sac 6/28; WT/PNE 9/26; HET/Sac 10/25; HET/PNE 10/28; ratio
of slices), which produced a significant PPF of ~1.2-1.3 and ~2/3 of the slices, which
produced no short-term plasticity (PPR ~1.0) as shown in Fig. 4.9. For each of the four G
 E groups, I quantified the changes in PPR for the 30 minutes after the recovery period
as well. Comparison of baseline and recovery for the four G  E groups did not reveal
significant differences in PPR before and after HFS for the PPF or no short-term
plasticity clusters. A two-way ANOVA comparing the baseline responses between these
groups for both the PPF and no short-term plasticity clusters, did not show a significant
effect of genotype, treatment, or a significant interaction of genotype  treatment between
groups with one exception. The no short-term plasticity cluster was significantly larger in
the HET/PNE group than the HET/Sac group. These results reveal that for each of the
four G  E groups, approximately 1/3 of slices exhibit short-term facilitation (PPF) and
approximately 2/3 of slices did not exhibit short-term plasticity. Importantly, with the one
exception mentioned above, there were no alterations in PPRs in the PPF or no short-term
plasticity clusters as a result of HFS.
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Fig. 4.9: Comparison of effects of PPF or no short-term plasticity on LTD induction
in the four G  E groups. Cluster analysis was performed on the baseline paired pulse ratios
(PPRs) for experiments grouped for all conditions (STD, LTD, in presence of CB1, or D2
antagonists). Each G  E group clustered into significant (p < 0.001) groups with either PPF or no
short-term plasticity (None). Comparison of baseline (B) PPRs to results 30 minutes after HFS
(R) do not reveal differences within groups for PPF and no short-term plasticity (None) clusters.
Comparison across groups revealed a significantly larger baseline no short-term plasticity cluster
for the HET/PNE group compared to the equivalent cluster in the HET/Sac group, but no other
group comparisons showed significance.

D2R agonist affinity and/or receptor coupling is altered in Snap25 heterozygotes
prenatally exposed to nicotine
To investigate further the role of D2R signaling in striatal synaptic depression, I
first performed [35S]-GTPS binding experiments to measure the agonist-stimulated
response of G-protein-coupled receptors (GPCRs) using the D2R/D3R-specific agonist
quinelorane (Sovago et al., 2001) in coronal sections of P35-50 mice of the four G  E
experimental groups. [35S]-GTPS binding is a common method to determine the effect
of an agonist on receptor affinity, downstream signaling, and/or number of receptors. The
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assay is based on agonist binding of the GPCR that leads to conformational changes in
the GPCR, enabling interaction with a G protein. GDP is released from the α subunit and
is replaced by [35S]-GTPS which is resistant to hydrolysis so remains bound to the α
subunit, so the radioactivity is a measure of agonist binding. The agonist binding,
reflected in accumulation of [35S]-GTPS, can measure changes in receptor number,
affinity, and/or receptor-effector coupling.
I measured the intensity of the signal over the dorsal striatum as previously
described (Martinez et al., 2008) to obtain both the basal level of GTP binding and
binding following half maximal and maximal agonist stimulation. As expected,
preliminary experiments demonstrated a concentration-dependent increase in response to
increasing quinelorane concentration over a range of 1 nM to 1000 µM that resulted in an
EC50 of approximately 20 M and EC100 of approximately 200 M in WT/Sac controls
(Fig. 4.10). The specificity of the binding was tested by co-incubating slices with 100
M quinelorane and a saturating level of the D2R/D3R-specific antagonist sulpiride (50
µM), which fully blocked the agonist-stimulated GTP binding in the same WT/Sac
controls (Fig. 4.10). Also shown in Fig. 4.10 are fits of the data to a Hill equation (see
Methods for details) from which the Kd was found to be 18.88 M, close to the 20 M
used for the EC50 value. The inset in Fig. 4.10 shows the hyperbolic relationship for
increased agonist binding as a function of concentration as is typical for MichaelisMenten kinetics where a ligand saturates a receptor with increasing binding.
Interestingly, the Hill equation fit for the WT/Sac group had a Hill coefficient of 0.314
indicating negative cooperative binding (Goutelle et al., 2008). Since only one replicate
was done only for the WT/Sac group, it is not possible to draw general conclusions about
this result. However the ramifications for this finding are discussed as a possible future
direction for further research in the Discussion.
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Fig. 4.10: Preliminary EC50 and EC100 binding. The total binding for each slide was
subtracted from the nonspecific slides incubated in the presence of 10 µM unlabelled GTPS
(each in turn determined by subtracting regions in the striatum from background as with total
binding) to determine specific binding for each data point. Binding from both the left and right
side of the striatum was used in the analysis. This figure shows a dose response curve for
quinelorane binding between 200 nM and 1000 µM. Inset shows same plotted with a linear. The
units are femtomoles/ 105 µm2. Values (mean ± SE) for specific binding at 100 µM was 0.146 ±
0.006; at 100 µM with 50 µM sulpiride was 0.039 ± 0.042, which compares with specific binding
at 200 nM quinelorane, which was 0.042 ± 0.005 indicating that quinelorane is specific for
D2R/D3Rs. The Hill equation fit indicated a Kd value of 18.88 µM, close to the 20 µM used for
the EC50 value, and a Hill coefficient n=0.314.

The results of these agonist-stimulated GTP binding experiments in the four G 
E groups are summarized in Table 4.1. Under basal conditions without quinelorane, a
two-way ANOVA revealed a significant effect of genotype on GTP binding (F(1,20)=5.89,
p < 0.05), although a post-hoc test failed to show any significance difference between the
groups. At half maximal stimulation with the agonist quinelorane (EC50; 20 µM), a twoway ANOVA revealed decreased [35S]-GTPS binding compared to the WT/Sac control
with significant effects of both genotype (F(1,20)=9.49, p < 0.01) and treatment
(F(1,20)=7.78, p < 0.05), although no significant interaction of genotype  treatment was
detected (F(1,20)=0.02, p =0.90). Post-hoc analysis of these data demonstrated that the
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stimulated receptor binding of GTP at the EC50 for quinelorane was significantly
decreased in the HET/PNE group compared to WT/Sac controls (~0.6 fold; p < 0.01),
indicating reduced activation of D2R signaling in the dorsal striatum of HET mice
exposed to prenatal nicotine. In contrast to the effects obtained at the EC50 concentration,
a two-way ANOVA of the data obtained at maximal stimulation (EC100; 200 µM )
revealed a significant effect of genotype (F(1,20)=7.20, p <0.05), but no significant effects
for treatment (F(1,20)=0.30, p =0.59), or for a genotype  treatment interaction
(F(1,20)=0.29, p =0.59). Moreover, post-hoc analysis of the EC100 data did not reveal any
significant differences between these groups. These results suggest that the synaptic
plasticity differences seen in the HET/PNE group may be due to changes in D2R
signaling, which is revealed only under limited agonist concentrations and might result
from either a decrease in receptor affinity and/or G-protein receptor-effector coupling.

Group

Basal Binding

WT/Sac
WT/PNE
HET/Sac
HET/PNE

0.049 ± 0.005
0.042 ± 0.006
0.035 ± 0.005
0.031 ± 0.004

EC50 (20 μM
quinelorane)
0.104 ± 0.007
0.085 ± 0.010
0.083 ± 0.004
0.066 ± 0.002**

EC100 (200 μM
quinelorane)
0.245 ± 0.011
0.254 ± 0.018
0.207 ± 0.011
0.223 ± 0.016

Table 4.1: Dopamine agonist, quinelorane simulated [35S]-GTP-γ-S binding. Comparative
values of the four G  E experimental groups for basal [35S]-GTP-γ-S binding without
quinelorane, net EC50 [35S]-GTP-γ-S binding with quinelorane at 20 µM, and net EC100 [35S]GTP-γ-S with quinelorane at 200 µM respectively. All samples in quadruplicate and binding is
5
2
given in femtomoles/10 μm . (mean ± SEM, n = 6 animals from which quadruplicate sections
were obtained). The net EC50 and EC100 binding represent net binding with basal binding
subtracted prior to analysis. Post-hoc tests for EC50 revealed HET/PNE group had significantly
less binding than other groups (p < 0.01).

Decreased [3H]-Quinpirole agonist saturation binding kinetics indicates decreases in
D2R affinity in Snap25 heterozygotes prenatally exposed to nicotine
To distinguish between a reduced affinity and number of expressed D2Rs, I next
performed agonist saturation binding experiments with the D2R selective radioligand
[3H]-quinpirole in striatal tissue homogenates (Levant et al., 1992) in order to determine
the Kd and Bmax for the four G  E groups. Saturation binding is a well established
method for quantifying the affinity of an agonist as well as the number of receptors
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present, and is complementary to the [35S]-GTPS binding assay for determining changes
in agonist affinity and number of receptors. For each experiment, specific binding was
determined at six agonist concentrations from 0.2 nM to 9 nM and the values of the Kd
and Bmax were determined by least-squares fits of data from replicate experiments (see
Experimental procedures). Fig. 4.11 shows a representative saturation isotherm obtained
from one of the WT/Sac striatal homogenate experiments. Fig 4.11A shows the total and
non-specific binding obtained over the range of agonist concentrations from which the
specific binding was obtained (total binding minus non-specific binding). Fig 4.11B
shows the plot of the ratio of the bound /free ligand as a function of the free ligand from
which the Kd can be determined from the slope (-1/slope) and Bmax values from the Xintercept according to Scatchard analysis. The isotherms as well as data associated with
samples used for all groups are presented in Appendix 1.
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Fig. 4.11: Representative saturation isotherm and Scatchard plot for [ H]Quinpirole D2R agonist saturation binding in WT/Sac striatal homogenates. Striatal
3
membranes were incubated with 6 concentrations of [ H]-Quinpirole (~0.2 – 9nM) at 23o C. Kd
and Bmax were estimated with least square fits to Scatchard plots of triplicate samples. A Plot of
3

total, non-specific and specific binding as a function of [ H]-Quinpirole concentration. B
Scatchard plot of ratio of bound/free ligand versus specific bound ligand fraction for the same
example.

Table 4.2 is a summary of the saturation binding kinetics obtained for the four G
 E groups. The Kd obtained for the HET/PNE group was markedly greater than the
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comparable values obtained for the other three groups. A two-way ANOVA of the Kd
obtained from each of the four experimental groups revealed a significant effect of
genotype (F(1,16)=20.01, p < 0.001), treatment (F(1,16)=5.36, p <0.05), as well as an
interaction of genotype  treatment (F(1,16)=5.15, p <0.05). Importantly, post-hoc analysis
demonstrated that the Kd for D2R receptor agonist binding of HET/PNE group was
significantly higher (~1.6 -2.1 fold; versus WT/Sac and WT/PNE, p < 0.01; versus
HET/Sac, p < 0.05) than the other groups (Table 4.2), indicating a reduced agonist
affinity for D2Rs in HET mice exposed to prenatal nicotine. In contrast to the Kd results,
no significant difference was found between the Bmax values determined for the four G 
E groups indicating that the number of receptors remained unchanged. Taken together
with the data obtained from the agonist stimulated GTP binding experiments, these
results suggest that G  E interactions affecting synaptic plasticity in the striatum, which
are reflected by impaired dopamine-dependent induction of LTD, are mediated through
changes in agonist affinity and possibly G-protein receptor-effector coupling as indicated
by the [35S]-GTPS results with subsequent effects on downstream G-protein signaling by
these D2 receptors.

Group

Kd (nM ± SEM)

Bmax (fmol/mg protein ± SEM)

WT/Sac
WT/PNE
HET/Sac
HET/PNE

3.322 ± 0.458
3.348 ± 0.599
4.562 ± 0.565
7.128 ± 0.606*,**

117.7 ± 15.5
128.0 ± 15.2
127.8 ± 15.7
119.5 ± 9.3

3

Table 4.2: [ H]-Quinpirole D2R agonist saturation binding kinetics.
Comparative values of Kd and Bmax for the four G  E experimental groups. All samples in
triplicate and values (mean ± SEM, n = 5, each n represents dissected striatal homogenates from 2
male and 2 female brains). Post-hoc tests for the Kd revealed HET/PNE group significantly
greater than **WT/Sac and WT/PNE (p < 0.01) and *HET/Sac (p < 0.05).
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Chapter 5 - Discussion
Summary of findings
Table 5.1 below, which includes F-values and significance for main gene,
environmental as well as gene-environmental effects, summarizes the major findings of
this research. The table also presents significant post-hoc effects measured when gene,
environmental or gene-environmental effects were found. The electrophysiological
results showed that the induction of LTD in the dorsal striatum by the HFS paradigm
resulted in distinct populations of responses in all four G  E groups, which I have
designated as STD and LTD. Additional experiments were performed with the WT/Sac
control group to confirm that the production of STD or LTD was not a function of the test
and HFS input ratios (nominally set at ~0.5 for all experiments). Between-group
comparisons of LTD populations revealed that LTD was less robust in the HET/PNE and
HET/Sac groups compared to WT/Sac controls due to a main gene effect and geneenvironmental interaction. Between-group comparisons of STD populations did not
reveal significant differences between groups, although the HET/PNE group showed less
recovery to baseline compared to other groups and there was a main effect of
environment. In the presence of a D2R antagonist, the HET/PNE group exhibited
significantly less recovery to baseline following HFS than the other groups indicating that
the induction of LTD is impaired by a process involving D2Rs. However, a CB1R
antagonist did not produce a significant difference between groups, confirming that the
alterations in LTD induction does not affect the endocannabinoid feedback control of
cortical glutamatergic input to medium spiny neurons (MSNs) that has previously been
shown to be responsible for LTD induction in the striatum (Lovinger, 2010). Additional
findings were that, although a greater percentage of slices from the HET/PNE mice
resulted in LTD than in STD, the ratio of LTD to STD responses (% fEPSPSTD / %
fEPSPLTD) was less for the HET/PNE group than that observed for the other groups. The
differences found for the HET/PNE group cannot be due to differences in intrinsic
excitability, since comparisons of half maximum stimulus intensities between the groups
showed no significant differences. Overall, these differences observed for STD and LTD
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are consistent with G  E interactions leading to pronounced impairments in the
induction of LTD in the HET/PNE group compared to other groups.
All electrophysiology experiments were carried out with a pair of stimulus pulses
separated by a 50 ms interpulse interval (IPI) in order to allow assessment of changes in
PPR before and after HFS. Comparisons of PPR within each group did not reveal
significant changes in any group for the STD and LTD populations or in experiments
done in the presence of a D2R or CB1R antagonist. Similarly, comparison between
groups also did not reveal significant differences in PPR before or after HFS for STD and
LTD populations, or in the presence of a D2R or CB1R antagonist.
These results suggest that the electrophysiology findings of an impaired induction
of LTD in animals with a combination of HET genotype and PNE treatment, could result
from changes in D2R affinity and/or changes in the number of D2R receptors, since in
the presence of a D2R antagonist, the induction of LTD was impaired. This was initially
tested using a [35S]-GTPS binding assay to measure the agonist-stimulated response of
G-protein-coupled D2R receptors. The agonist-stimulated response was reduced in the
HET/PNE group when compared to the WT/Sac control group, consistent with the
reduction in agonist affinity for the D2R receptor, and/or reduced GPCR – trimeric G
protein coupling, which would reduce downstream signaling from the GPCRs (since this
assay measures G-protein activation from agonist-stimulated GPCR response, this
response could be due to changes in affinity, receptor-effector coupling, or both).
Moreover, the decreased agonist-simulated response, observed at the EC50, but not at the
EC100, in the gene and environmental, but not gene-environmental groups, supports the
conclusion that the receptor number was not altered by this G  E interaction. Next, a
D2R agonist saturation binding assay, using [3H]-quinpirole (a D2R selective agonist)
followed by Scatchard analysis, showed that the HET/PNE group exhibited significantly
lower affinity (higher Kd) for D2R binding without a significant change in Bmax that
would reflect a change in the number of receptors.
Collectively, these results argue strongly that the combination of the HET
genotype and prenatal nicotine exposure (G  E interaction) leads to an impaired D2R
GPCR signaling resulting from decreased agonist affinity and possibly receptor-effector
coupling of the D2R receptors. These receptor binding observations are consistent with
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the electrophysiological results showing that, in the presence of a D2R antagonist,
cortico-striatal circuits in HET/PNE mice exhibit significantly less recovery following
HFS than the other groups indicating that the induction of LTD is impaired. Importantly,
the finding that CB1Rs are not similarly affected confirms that the deficit in synaptic
plasticity precedes the endocannabinoid feedback control of cortical glutamatergic input
to medium spiny neurons (MSNs) that is responsible for inducing LTD in the striatum
(Lovinger, 2010).

Main Effect
Experiment

Interaction

Gene

Environment

Snap25

PNE

GxE

Post-Hoc

HFS induction of LTD
LTD

F=23.8***

F=0.2

F=12.4**

WT/Sac**1

STD
D2R Antagonist
CB1R Antagonist

F=1.1
F=10.1**
F=0.1

F=5.2*
F=5.7*
F=1.6

F=2.3
F=6.0*
F=2.1

HET/PNE**3

Quinelorane simulated [35S]-GTP-γ-S binding
Basal

F=5.9*

F=1.2

F=0.1

Net EC50

F=9.5**

F=7.8*

F=0.02

Net EC100

F=7.2*

F=0.3

F=0.3

HET/PNE**2

[3H]-Quinpirole dopamine agonist saturation binding kinetics
Kd

F=20.0***

F=5.36*

F=5.2*

Bmax

F=0.0

F=0.0

F=0.4

HET/PNE**3

Table 5.1: Summary of overall results. Table shows F values and significance of twoway ANOVAs carried out for each experiment for main G  E effects as well as G  E
interaction effects. For experiments with main effects, the table indicates significant post hoc
effects. Notes: 1. WT/Sac was significantly different from HET/Sac and HET/PNE only. 2.
HET/PNE was significantly different from WT/Sac only. 3. HET/PNE was significantly different
from WT/Sac and WT/PNE and HET/Sac. (* p<0.05; ** p<0.01; *** p<0.001)

Relationship between STD and LTD
Cluster analyses of my data indicated that the HFS paradigm produces STD as
well as LTD in all four G  E groups. Two distinct, but related, questions arise
concerning these results. First, what accounts for the variability in the production of STD
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and LTD for a given experiment (brain slice), and second what is the relationship
between STD and LTD. Although these questions are incidental to the hypothesis, they
address interesting aspects of the mechanisms of long-term synaptic plasticity and field
potential summation.
As noted, experiments were performed with WT/Sac controls to determine
whether the production of STD or LTD was not a function of the test to HFS stimulus
intensity ratio. Although varying this ratio between ~0.3 and ~0.7 did produce a slight
increase in the final PS amplitude, the correlation was extremely weak (see Results; Fig.
4.2). To minimize any possible contribution from the test to HFS stimulus intensity ratio,
this ratio was set at 0.5 and was always within a range of ~0.4 to ~0.6.
Experiments were done with hemislices, and there were cases where, for example,
the left hemislice produced LTD while the right hemislice produced STD or both
produced LTD or STD. So the production of LTD or STD does not seem to be slice
dependent.
It is possible that there are regional differences in the expression of STD and LTD
within the striatum. Lovinger and colleagues (Partridge et al., 2000) found in voltageclamped neurons from P16- P34 Sprague Dawley rats that HFS of the dorsomedial (DM)
striatum was more likely to produce LTP whereas HFS of the dorsolateral (DL) striatum
was more likely to produce LTD. My results were all from field potential recordings from
P35-P50 mice and were predominantly in the DL striatum. There was considerable
difference in developmental stage between these two studies with the mice used in my
experiments being at a much later developmental stage than the rats in the previously
published experiment (Partridge et al., 2000). Also, it is difficult to compare results
obtained from single cells from whole-cell voltage-clamping to the mixed populations of
cells that contribute to the field potentials in my research.
Another possibility is that the differences between STD and LTD could reflect
differences in proportions of cortical and thalamic inputs to MSNs. It has been previously
demonstrated that the glutamatergic input to MSNs is ~60% cortical and ~40% thalamic
(Surmeier et al., 2007). Using an slightly oblique (~20 degree) horizontal slice, which
permitted stimulating selectively cortical or thalamic inputs to individual voltageclamped MSNs, Surmeier and colleagues found that cortical inputs had a PPR (50 ms
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IPI) of ~1.2 and thalamic input cells had a PPR of ~0.8 (Ding et al., 2008). These
researchers also found that repeated stimulus trains resulted in short-term enhancement of
EPSCs for cortical inputs and depression of EPSCs for thalamic inputs. I found that the
PPR of the PSs for all G  E groups was ~1.1 (Fig. 5.8) and, when these groups were
further separated into populations using cluster analysis, I found one population with a
PPR of ~1.2 (~1/3) and another with a PPR of ~1.0 (2/3) (Fig. 5.9). This indicates that
while the inputs in my experiments are certainly a mixture of cortical and thalamic fibers,
they are likely to be predominantly cortical, since the PPRs are closer to those found for
cortical inputs. Importantly, I did not find a correlation between the PPR and the
likelihood of producing LTD or STD in a given experiment. It seems unlikely that the
differences between LTD and STD could be accounted for by differences between
cortical and thalamic inputs.
As discussed in Appendix 2, the distribution of STD and LTD clusters is affected
by the HFS paradigm used to induce long-term plasticity. Importantly, all of the
experiments reported here used the same HFS paradigm and that paradigm is the most
commonly used in previously published reports. It would be interesting to investigate in
the future whether further distinctions among the G  E groups are revealed by using
other HFS paradigms.
As stated in the introduction, MSNs make up ~90% of all neurons in the striatum
and they are roughly evenly divided between those expressing D1Rs (direct pathway) and
those expressing D2Rs (indirect pathway). Using whole-cell voltage-clamped neurons
from transgenic mice labeled with bacteria artificial chromosome (BAC) either for direct
or indirect MSNs, it was shown that only D2-type indirect neurons undergo
endocannabinoid-dependant LTD following HFS (Kreitzer and Malenka, 2007). One
possibility is that individual field potential experiments selectively target sub-populations
of MSNs, which consist predominantly of D1R-or D2R-expressing neurons. Field
potentials that included predominately D1R neurons would undergo STD and those
including predominately D2R neurons would undergo LTD. However immunoreactive
staining of 1 mm2 sections to differentiate D1R and D2R expressing MSNs revealed a
fairly homogenous distribution both types of MSN (Penny et al., 1986). Given that field
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potentials sum responses of a large population of individual neurons, it is unlikely that
selective STD or LTD responses could be due to sub-populations of D1R or D2R MSNs.
Another issue, which may be relevant to the relationship between STD and LTD,
is the relative thresholds of glutamatergic and dopaminergic inputs necessary to obtain
STD and LTD. As described in the introduction, striatal MSNs receive convergent
glutamatergic input that depolarizes them and activates mGluRs as well as dopaminergic
input that activates D2Rs. This convergent input is necessary to produce
endocannabinoids that act pre-synaptically on CB1Rs, in order to initiate the induction of
LTD. Lack of either sufficient glutamatergic or dopaminergic input would not allow
sufficient production of endocannabinoids for the induction of LTD. According to this
hypothesis, populations of cells, which lack sufficient glutamatergic or dopaminergic
input, would undergo STD, but not LTD. For a given field potential experiment, the
fEPSP depends on the location of the stimulating electrode and hence the population of
MSNs whose potentials are summed. It is conceivable that some summed populations of
MSNs may receive sufficient input to produce a population spike, but not sufficient input
to induce LTD after HFS. Given that other options considered seem less likely, this
seems to be the most promising possibility.
All experiments in all four G  E groups, exhibited an initial depression in the PS
amplitude to ~20% of baseline (post-tetanic depression; PTD) whether the amplitude
subsequently returned to baseline after 30 minutes (STD) or remained attenuated at near
the level of the initial PTD (LTD). This suggests that STD and LTD may be causally
related. The PTD is most likely due to short-term depletion of vesicles in the readily
releasable pool (RRP) following HFS (Citri and Malenka, 2008). Pre-synaptically, it has
been estimated that individual vesicle recycling can occur in as little as 30s (Ryan et al.,
1993). Recycling a pool of vesicles following HFS may take longer, but it unlikely to
take the 15-20 minutes that would be necessary to account for the recovery dynamics
associated with STD. Post-synaptically, activity-dependent clathrin-mediated AMPA
internalization and reinsertion has been extensively investigated (van der Sluijs and
Hoogenraad, 2011). For example, in hippocampal cell cultures using fluorescent imaging,
AMPA receptors were observed to rapidly internalize (<30s) followed by a slow return to
baseline levels (~600s) when the stimulus was terminated (Ashby et al., 2004). There has
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been little research on AMPA trafficking in MSNs to determine whether the same
dynamics exist in this cell type. However we can speculate, given the fact that AMPA
recycling following a stimulus takes ~10 minutes, that this may be a key mechanism
involved in the dynamics of STD, since the recovery dynamics most closely align with
those seen in STD in the four G  E groups. LTD has been shown to have a significant
pre-synaptic component and could be superimposed on STD when sufficient
glutamatergic and dopaminergic input leads to the production of endocannabinoids,
which bind retrogradely to activate pre-synaptic CB1 receptors to suppress glutamate
release. The model of the relationship of LTD and STD based on these considerations is
illustrated in Fig. 5.1 below.
As noted in the Results, the WT/Sac group had a shorter time constant for STD
than the other groups. This may indicate that as a result of the G  E factors and
interactions, the rate of AMPA trafficking in MSNs has increased (Fig 4.7B). In the
presence of D2R antagonists there were no distinct differences between groups (Fig.
4.7C), so although D2R antagonists affect LTD induction, they do not appear to alter the
rate of AMPA trafficking. Interestingly, in the presence of CB1 antagonists, there was a
surprising ~3 fold increase in the time constant for the HET/PNE group compared to
other groups (Fig. 4.7D). The PS did recover to baseline 30 minutes after HFS, so CB1
antagonists were able to block LTD induction, but with a longer time constant. Binding
of endocannabinoids on pre-synaptic CB1 receptors is considered the last step of the
process which occurs in LTD induction. The fact that the HET/PNE group showed
increased time constant could indicate that the rate of AMPA trafficking is slowed due to
G  E factors and interactions, complementing the more modest time constant increases
found for STD.
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Figure 5.1: Model of relationship of STD and LTD. Following HFS, glutamate
vesicles in the pre-synaptic RRP are depleted causing initial PTP. At the same time the HFS leads
to activity dependent AMPA receptor internalization. STD is proposed to be due to the dynamics
of AMPA internalization and membrane reinsertion. LTD is proposed to undergo the same PTP
and AMPA internalization associated with STD. However, with sufficient glutamatergic and
dopaminergic input, post-synaptic endocannabinoid production occurs with subsequent retrograde
transmission to the pre-synaptic terminal where it binds to CB1 receptors causing a long-term
decrease in glutamate release associated with LTD.

Changes in PPR for STD and LTD
Changes in PPR are often used as a measure of changes in the probability of
transmitter release (PR) in the presynaptic terminal in response to the second stimulus
compared to the first stimulus (Citri and Malenka, 2008). Synapses with a high initial PR,
will be dominated by depletion of the RRP of vesicles resulting in PPD (Zucker and
Regehr, 2002). By contrast, in synapses with a low initial PR, the remaining residual Ca2+
from the influx of first stimulus will combine with the Ca2+ influx due to the second
stimulus resulting in PPF (Zucker and Regehr, 2002). I compared changes in PPR before
and after HFS, but did not find differences between STD and LTD populations in any of
the G  E groups. This may indicate that PPR is not a sensitive enough marker of pre-
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synaptic contributions to distinguish between STD and LTD. An increase in PPR has
been found in striatal MSNs using a similar HFS protocol in whole-cell voltage-clamp
recordings indicating a decrease in probability of release of glutamate in presynaptic
terminals (Choi and Lovinger, 1997b). These researchers did not examine changes in
PPR during STD. The fact that I did not observe similar changes using field recordings in
the G  E groups could indicate that PPR may vary considerably within a population of
neurons and this may obscure changes in PPR that occur at individual neurons.
Regardless, my observation that CB1 antagonists depress LTD induction in WT/Sac
controls, supports the consensus (Lovinger, 2010) that LTD induction in my experimental
conditions results from a long-term decrease in presynaptic glutamate release due to
retrograde transport of endocannabinoids to presynaptic terminals.
G  E factors and interactions impair induction of LTD in the striatum and
decrease D2R affinity and/or receptor-effector coupling
I have shown that the combination of the HET genotype and prenatal nicotine
exposure (G  E interaction) leads to an impaired D2R GPCR signaling resulting from
decreased agonist affinity and possibly receptor-effector coupling of the D2R receptors.
Impairment of D2Rs has also been implicated by the impaired ability to block LTD in the
presence of D2R antagonists.
As outlined in the Introduction, the current understanding is that HFS-dependent
LTD induction in the striatum is due to convergence of glutamatergic activation of
MSNs, which depolarizes them causing the transition from the resting DOWN state with
a membrane potential of ~-85 mV to an active UP state with a membrane potential of ~55 mV with simultaneous dopaminergic input. Because blockade of either D2Rs or
metabotropic glutamate receptors (mGluRs) prevents LTD induction in the striatum with
the HFS paradigm, activation of both receptor types post-synaptically is necessary for
this process to occur (Lovinger, 2010). The glutamate activation of mGluRs and
dopamine activation of D2Rs independently contribute to the opening of CaV1.3 L-type
Ca2+ channels and the subsequent production of endocannabinoids by the MSNs
(Surmeier et al., 2007; Wang et al., 2006). These endocannabinoids diffuse retrogradely

75

to act on pre-synaptic CB1 receptors on glutamatergic terminals leading to long-term
depression of glutamate release (Lovinger, 2010).
This role of D2Rs in striatal LTD is underscored by my findings that the
combination of the HET genotype and prenatal nicotine exposure leads to a decreased
affinity and signaling in one or more populations of D2Rs, and this appears to both
impair the induction of striatal LTD and to reduce the relative magnitudes of both LTD
and STD.
These observations raise two broad sets of questions. First, how do G  E factors
mechanistically contribute to the changes in D2R affinity and/or receptor coupling? Since
D2Rs are expressed in MSNs as well as dopaminergic and glutamatergic terminals and
on cholinergic interneurons, we need to consider whether changes in D2R affinity and/or
receptor coupling affect all or only a subset of these receptors. Second, how can changes
in D2R affinity and/or receptor coupling as a result of G  E factors and interactions
impair LTD induction? The two questions are addressed in consecutive sections below,
which also include future directions that address and resolve distinct possibilities for
each.
G  E factors and interactions decrease D2R affinity and/or receptor-effector
coupling
I will consider here how these G  E factors and interactions could potentially
alter D2R affinity and/or receptor-effector coupling, which in turn could lead to
impairments of downstream signaling. As summarized in Figure 5.2, our results suggest
that there is decrease in both D2R GPCR affinity and G-protein receptor-effector
coupling ([35S]-GTPS binding assay results), but the number of receptors have not been
significantly altered by the combination of HET genotype and prenatal nicotine exposure.
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Figure 5.2: G  E factors and interactions alter D2R affinity and possibly receptoreffector coupling. The figure shows the basic layout of the D2R GPCR and coupled G proteins
and downstream effectors to show that D2R affinity and/or receptor coupling has been decreased
by G  E factors and interactions in the HET/PNE group compared to the WT/Sac group. These
G  E conditions may alter dopamine release as well as alter other neurotransmitters and
receptors to effect the changes in a developmental and/or use dependent manner.

One consideration is the role of the HET genotype in changes in D2R affinity.
Preliminary evidence from in vivo microdialysis assays as discussed in the Introduction
indicates that heterozygous Snap25 null mutants (equivalent to HET/Sac group) have
increased evoked extrasynaptic dopamine in the striatum compared to their wild type
littermates (equivalent to WT/Sac group) (Fan, Wilson, Hess, unpublished observations).
This suggests that the decreased expression of SNAP-25 in the HET/Sac group may
result in enhanced dopamine release and this might act as a precondition for the
decreased D2R agonist affinity/receptor-effector coupling and subsequent downregulation of receptor signaling that is responsible for modulating striatal activity. These
mice have decreased evoked extrasynaptic glutamate in the striatum compared to their
wild-type littermates, which could also factor into the decrease in D2R agonist affinity,
since NMDA, AMPA, and mGluR receptors are expressed on glutamatergic inputs to
MSNs, and striatal dopamine release has been shown to be altered by changes in
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glutamate release (David et al., 2005). Beyond these preliminary results, little is known
about how developmental and/or use dependent changes, which occur with Snap25
haploinsufficiency can effect glutamate and dopamine release in the striatum
(Washbourne et al., 2002).
Another consideration is the role of prenatal nicotine exposure in changes in D2R
affinity. As discussed in the Introduction, various subtypes of the nicotinic acetylcholine
receptor (nAChR) are expressed in striatal glutamate and dopamine terminals, as well as
on MSNs and cholinergic interneurons (Fig. 5.1) (Quik et al., 2007). Activation of these
receptors can alter dopamine release onto MSNs (Threlfell et al., 2012). Nicotinestimulated release of dopamine has been shown to be decreased in synaptosomes
prepared from the striatum of adolescent rats prenatally exposed to nicotine (Gold et al.,
2009). By down-regulating the nAChR modulation of dopaminergic terminals, the
persistent effect of early nicotine exposure might be expected to lead to a downregulation of dopamine release onto striatal MSNs. Importantly, nAChR antagonists
have been shown to block LTD induction (Partridge et al., 2002) suggesting that prenatal
nicotine may act on these nAChRs to additionally impact the induction of LTD through
its effects on dopamine release leading to alterations in D2R affinity and/or receptoreffector coupling.
Deficiencies of SNAP-25 and persistent effects of prenatal nicotine exposure
may, therefore, converge on dopaminergic transmission in the striatum. Preliminary
microdialysis measurement suggest that the HET/Sac genotype leads to increases in
dopamine release and decreases in glutamate release, while prenatal nicotine exposure
leads to decreases in dopamine release. The results presented here indicate that neither
the HET genotype (HET/Sac group) nor prenatal nicotine exposure (WT/PNE group) are
associated with distinct differences in D2R affinity and/or receptor-effector coupling
compared to controls. Only combined G  E factors and interactions produced reductions
in affinity and/or receptor coupling. Thus, while the HET genotype and prenatal
exposure to nicotine could have distinct effects on dopamine as well as glutamate release
through different mechanisms, the interaction between these two conditions must affect
the homeostatic regulation of dopaminergic signaling to result in a reduced affinity and/or
receptor-effector coupling, which in turn can reduce downstream signaling of D2Rs.

78

Further research needs to be undertaken to determine how the combination of HET
genotype and prenatal exposure to nicotine alters dopamine release and effects D2R
affinity. A first step could be to perform in vivo microdialysis measurements in the four G
 E groups to determine whether dopamine and glutamate efflux are enhanced or reduced
in the HET/PNE group relative to the HET/Sac group.
Another important question regards the types of D2R receptors that are affected
by the G  E interaction. The [3H]-Quinpirole agonist saturation assay may indicated
changes in the affinity of all D2-class receptors expressed in the striatum. Quinpirole,
used to determine the Kd and Bmax values, is a selective D2-class receptor agonist with
affinity for all three D2-class receptor types: D2, D3, and D4 receptors (Seeman and Van
Tol, 1994). Quinelorane used in the [35S]-GTPS binding assay is selective for D2Rs and
D3Rs, but not D4Rs. As discussed in the Introduction, all D2-class receptors are
expressed in MSNs in the dorsal striatum with D2Rs normally expressed ~2 fold higher
than D3Rs and D4Rs combined (Surmeier et al., 1996). One interesting possibility is that
our results reflect different changes in affinity or relative numbers of functional receptors
for each of the D2-class receptor subtypes, so the Kd and Bmax values determined
represent values for the aggregate changes of the combination of all of these receptors,
while the [35S]-GTPS binding assay represents possible alterations in D2Rs and D3Rs.
These values are more likely due to changes in D2Rs, since they have the highest levels
in expression, but a large change in affinity one of the other two subtypes could mask
small changes in D2Rs. Some of the variability of the Kd and Bmax values in individual
experiments found in the Scatchard plots obtained from [3H]-quinpirole saturation
binding assays (see Appendix 2) could be reflective of different levels of individual D2class receptor subtypes in striatal homogenates, which could alter these values in a given
experiment if the changes predominantly occur in one subtype. In future experiments,
specific D2R, D3R, and D4R agonists could be used in binding experiments to dissect
this and determine if changes occur in all receptor subtypes or are predominant only in
one type. S-sulpiride, used here as a D2R antagonist in the electrophysiology LTD
induction experiments has a high affinity for D2R and D3R, but not D4R receptors
(Seeman and Van Tol, 1994). So far, only D2Rs have been implicated as having a role in
LTD induction, so impairment of LTD induction in the HET/PNE group relative to
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controls seems to implicate D2Rs, and not D3Rs or D4Rs. This does not mean that D3Rs
and D4Rs may not also be altered by these G  E factors and interactions.
As described in the Introduction, it is known that the D2 receptor can exist in
either a state of low or high affinity for dopamine (D2Low or D2High, respectively) and it is
possible to determine the relative levels of each affinity state (Seeman et al., 2006). The
D2Low state represents the condition where the D2R GPCR is uncoupled from the
heterotrimeric protein (Gαi/o,Gβ,Gγ) and the D2High state represents the condition where
the D2R GPCR is coupled and this latter state is more readily able to bind dopamine and
D2R agonists (van Wieringen et al., 2013). There are two alternative models that explain
GPRC coupling interactions with G proteins prior to agonist binding (Hein and
Bunemann, 2009). One model asserts that GPCRs and G proteins are not associated prior
to agonist binding, only coupling upon agonist binding. An alternative model asserts that
GPCRs and G proteins can stably associate with each other prior to agonist binding.
There is evidence supporting both models, but no consensus on which if either is the
predominate mode of coupling (Hein and Bunemann, 2009).
Using Scatchard analysis, I found Kd values for WT/Sac controls (Kd = 3.32 nM;
Table 4.2) similar to those found in the literature using the same methods (Levant et al.,
1992) and these were significantly decreased in the HET/PNE group (Kd = 7.13 nM;
Table 4.2). A study using rat striatal homogenates using techniques that distinguish
between dopamine binding to the D2Low and D2High affinity states found that about ~77%
of D2Rs are in the D2High affinity state (Kd = 43 nM) versus the D2Low affinity state (Kd =
4.55 µM). The Kd values that I determined in the saturation assay most likely reflect
values for D2High affinity states, since they are closest to those found for this state. One
method to distinguish between D2Low and D2High affinity states involves using a
competition binding assay for labeled D2 agonists [3H]-raclopride or [3H]-spiperone in
the presence of a range of dopamine concentrations in either low or high NaCl tris-buffer
(Seeman et al., 2005). The high affinity states are not detected in the presence of high
NaCl, so the values and relative levels of low and high affinity states can be determined
using this method. The D2R high affinity state is inhibited by Na+, and promoted by
Mg2+, through their influence on the binding crevice associated with the D2R agonist
binding site. Furthermore, the GPCR – G protein interaction is inhibited in the presence
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of high levels of GTP (Hein and Bunemann, 2009) so the concentration of all of these
factors must be taken into account when designing a binding assay. A shift towards a
higher proportion of D2Low affinity states, as a result of the G  E interaction, could
account for the results I observed, since the net effect would be an overall decrease in
D2R affinity. The [3H]-raclopride or [3H]-spiperone competition assay could be
performed to determine the relative amounts of D2Low and D2High affinity states in the
four G  E experimental groups to determine whether there was a change in the relative
levels of these states.
Finally, as described in the Introduction, it has been also shown that the D2
receptor has two isoforms, designated as the long D2L and short D2S isoforms, that are
generated by alternative splicing., The former is differentiated by an additional 29 amino
acids in the third intercellular loop (Usiello et al., 2000). The D2S is predominantly
expressed pre-synaptically on glutamatergic, dopaminergic, and cholinergic terminals
synapsing onto MSNs (Fig. 6.2) and D2L is expressed predominately post-synaptically
on MSNs spines (Usiello et al., 2000). Additional experiments performed by cross
breeding D2L null mice with the HET group, either exposed or not to prenatal nicotine,
followed by repetition of the saturation binding assays that distinguish D2Low and D2High
affinity states would distinguish changes in the D2 isoforms and thus indicate pre- vs.
postsynaptic involvement.
Mechanisms of D2R activation, including desensitization in response to high
levels of agonists, and subsequently resensitization when agonist exposure is reduced for
(Beaulieu and Gainetdinov, 2011) have been extensively studied. A common mechanism
for desensitization involves phosphorylation of an activated D2R by G protein-coupled
receptor kinases (GRKs) followed by the recruitment of adapter proteins termed arrestins
at specific sites on GPRC intracellular loops and COOH terminals. This leads to
blockage of GPCR downstream signaling and/or receptor internalization (Beaulieu and
Gainetdinov, 2011). One candidate kinase in the modulation of D2R signaling is GRK2,
and GRK2 expression levels have been shown to be altered in animals with
Parkinsonianism. In addition, cocaine treatment of GRK2 heterozygous mice produces
hyperactivity that is associated with ADHD (Gainetdinov et al., 2004). Another important
family of G protein modulators that play a role in D2R agonist binding are the regulators
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of G protein signaling (RGSs), which help regulate the rate of G protein hydrolysis and
thereby turn off G protein signaling,. RGS9-2 has been recently shown to be involved in
regulating the responses to psychostimulants upon agonist binding to D2Rs (Beaulieu and
Gainetdinov, 2011). However, although both ligand binding sites and potential residues
involved in phosphorylation of both D2L and D2S GPCR isoforms particularly in the
third intracellular loop are known, little is known about how binding of these sites either
by ligands or phosphorylation by kinases is linked to changes in D2R affinity or receptoreffector coupling (Vallone et al., 2000). Protein kinase A (PKA) and protein kinase C
(PKC) also have phosphorylation sites, which may be involved in desensitization of
D2Rs (Beaulieu and Gainetdinov, 2011). There is evidence that D2Rs may expressed as
either dimers or tetramers with the consequence that the binding of agonist to the first
receptor leads to negative cooperativity and reduced binding of subsequent receptors
(Seeman et al., 2006), The Hill coefficient of 0.314 that I found in the WT/Sac control
experiment for the [35S]-GTPS binding assays (Results; Fig 4.10) may be indicative of
this process and further follow-up experiments on the four G  E groups might reveal if
this is the case. While I have demonstrated that these G  E factors and interactions can
reduce affinity and/or receptor-effector coupling in D2Rs, and it is recognized that
GRK/arrestin signaling may play a role in alterations in these processes, it still remains to
be determined which signaling pathways are linked to alterations in affinity and/or
receptor-effector coupling. Primary research, which links changes in affinity of D2Rs to
the phosphorylation of specific D2R sites, would contribute to a fuller understanding of
this process.
G  E factors and interactions impair induction of LTD in the striatum
As a result of genetic, environmental and gene-environmental interactions, the
HET/PNE group showed a significant decrease in the ability of D2R antagonists to
impair LTD induction and this effect was not observed in the presence of a CB1
antagonist (Table 5.1). As discussed, reductions in D2R affinity and/or receptor-effector
coupling were revealed by the [3H]-quinpirole agonist binding and [35S]-GTP-γ-S binding
experiments, although it cannot be ruled out that there were parallel changes in D3Rs or
D4Rs affinity (though the [35S]-GTP-γ-S results using quinelorane don’t implicate D4Rs
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since it is not specific for D4Rs). As noted, S-sulpiride, used as a D2R antagonist in the
electrophysiology experiments is a selective D2-class receptor antagonist with affinity for
two of the three D2-class receptor types: D2R and D3R, but not D4 receptors (Seeman
and Van Tol, 1994). Since only D2Rs have been implicated in the LTD induction
process, the significant decrease in the ability of the antagonist S-sulpiride to impair LTD
must be primarily through its effects on D2Rs, although it may also have effects on
D3Rs. However, I will limit the remaining discussion to effects on D2Rs.
As discussed in the Introduction, the precise role D2Rs in the induction of LTD in
the striatum has not been fully established, because the D2Rs involved in the induction
process may be found alternatively on MSN spines (Fig. 5.3; path1) or associated with
cholinergic interneurons (Fig 5.3; path2). Since MSNs are the predominant neuron in the
striatum the changes in affinity and possibly receptor-effector coupling for D2Rs,
associated with the impairment of the induction of LTD, most probably reflects D2Rs
associated with MSN spines (Fig 5.3; red M). However, this does not preclude the
involvement of D2Rs associated with cholinergic interneurons (Fig 5.3; red C) or
glutamatergic and dopaminergic inputs (Fig. 5.3; red *) which could also undergo
changes in affinity and receptor-effector coupling.
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Figure 5.3: D2Rs involved in LTD induction of Striatal MSNs. The figure illustrates
the circuit on a MSN spine associated with induction of LTD (glutamatergic and dopaminergic
inputs to MSNs) along with cholinergic interneurons. Potential pathways for LTD induction are
shown and described in the inset. The two paths in which D2Rs may be involved in LTD
induction are shown. Locations of D2Rs associated with MSNs (red M), cholinergic interneurons
(red C) as well as glutamatergic and dopaminergic inputs (red *) in the LTD induction pathway
are shown.

Impairment of the induction of LTD in the striatum in the HET/PNE group and
coincident alterations in D2R affinity and possibly receptor-effector coupling suggests
that the role of D2Rs in the induction process has been altered. In the presence of
saturating levels of D2R antagonist, available D2Rs should be blocked thereby
preventing dopamine-dependent endocannabinoid production associated with LTD. In the
presence of a D2R antagonist the HET/PNE group only recovered by ~0.6 – 0.7 fold
compared to the other groups. The attenuation in recovery when D2R binding is blocked
suggests that endocannabinoids are produced in HET/PNE mice independent of the D2Rdependent pathway. This demonstrates that the G  E interaction during brain
development selectively affects the D2R-mediated, but not the CB1-mediated response to
HFS in the HET/PNE group suggesting that endocannabinoid release has been decoupled
from D2R involvement in LTD induction these animals. This implies that the reduction in
84

D2R affinity and possibly receptor-effector coupling has impaired the signaling pathway
downstream from D2Rs that culminates in the production of endocannabinoids
(Introduction; Fig. 1.4). Downstream signaling from both mGluRs and D2Rs have been
implicated in the production of endocannabinoids. One possibility is that mGluRs in the
HET/PNE group are able to induce LTD independent of D2R input, due to the
developmental or used-dependent changes introduced by these G  E factors and
interactions. Bath application of mGluR agonists has been shown to induce LTD in
MSNs and this LTD was enhanced in the presence of a sufficient concentration of D2R
agonists (Kreitzer and Malenka, 2005) suggesting that the inputs to these receptors work
synergistically in the induction of LTD. An important follow-up experiment would be to
test how the four G  E groups respond to the application of an mGluR agonist in the
presence or absence of a D2R antagonist. If both mGluR and D2R receptors work
synergistically, we would expect induction of LTD to occur selectively in the HET/PNE
group in the presence of a D2R antagonist.

Implications for neuropsychiatric disorders
As discussed in the Introduction, the SNAP25 gene is a candidate susceptibility
gene for both ADHD and schizophrenia, and prenatal exposure to nicotine has been
shown to be a significant risk factor for ADHD. Recently behavioral research to assess
spontaneous locomotor activity and social interaction using the same G  E experimental
groups were published in conjunction with the main findings presented here (Baca et al.,
2013). A major behavioral finding of that research is that the HET/PNE group, but not
the HET/Sac group, showed hyperactivity with respect to WT/Sac controls indicating that
G  E factors and interactions are critical to this hyperactivity. Another finding of that
study was that the HET/PNE group showed impairments in social interaction, which may
be relevant to mouse models associated with schizophrenia. The SNAP-25 haplodeficient
coloboma mouse mutant is a well established model of ADHD, since it displays
hyperactivity, ameliorated by amphetamine, as well as inattention and impulsivity (Fan et
al., 2012) and our previous study was in part aimed at extending the coloboma model by
showing that both Snap25 haploinsufficiency and prenatal nicotine exposure are
necessary for this hyperactivity. Importantly the amphetamine responsiveness was shown
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to be ameliorated through D2Rs and not D3Rs and D4Rs (Fan et al., 2010). The
coloboma mouse mutant microdeletion contains Snap25 plus 10 or more additional genes
(Hess et al., 1994), indicating that these other genes may contribute to the underlying
behavioral endophenotype. Together, these studies might provide a genetically defined
mouse model that may contribute further to our understanding of the crucial role played
by gene-environmental interactions in neuropsychiatric illnesses, such as depressive
disorders, ADHD, schizophrenia, obesity, and substance abuse (Wermter et al., 2010).
Given that the SNAP25 gene is a candidate susceptibility gene for both the
neuropsychiatric disorders ADHD and schizophrenia, and that prenatal nicotine has been
shown to be a significant risk factor for ADHD, a natural follow-up is to explore the
implications of these G  E factors in synaptic plasticity that is associated with known
brain regions and receptors associated with these disorders. As discussed in the
Introduction, there is growing evidence for the influence of long-term synaptic depression
in the striatum being linked to learning and behavior (Lovinger, 2010; Yin et al., 2009)
with possible links to these disorders. The electrophysiological and affinity findings
reported here may align with the hyperactivity and impairments in social interaction,
which have been found to be associated with the same G  E factors and interactions. An
interesting follow-up would be to determine if coloboma mouse mutants show similar
reductions in D2R affinity and impairments in LTD induction in the striatum.
Significant genetic association has been reported between ADHD and single
nucleotide polymorphic (SNP) variants of SNAP25 (Faraone et al., 2005). The
involvement of both the protein and gene for SNAP25 in dopaminergic transmission
suggests that alterations in SNAP25 gene regulation and expression along with
environmental factors may confer susceptibility to these disorders by affecting synaptic
plasticity in the striatum may underlie the aberrations of behavior seen in ADHD and
other psychiatric disorders such as schizophrenia. Follow up work to this research could
examine whether other identified G  E factors in ADHD and other neuropsychiatric
disorders are associated with similar reductions in D2R affinity and impairments of LTD
induction. As shown in this research, the use of targeted mutations as well as challenges
with identified environmental factors can be an important tool to dissecting the
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mechanisms that may underlie specific behaviors associated with neurocognitive
disorders.

Future directions
The results of this study support the overall hypothesis that G  E factors and
interactions, which result from Snap25 haplodeficiency and prenatal nicotine exposure in
mice, lead to long-term impairments in D2 receptor affinity and possibly receptoreffector coupling in striatal MSNs with resultant impairments in the process of striatal
LTD induction. The Discussion includes consideration of several important questions that
should be addressed in future studies. The following section highlights three additional
issues that are central to the interpretation of the results of this study, but were not
previously considered. I have proposed specific hypotheses that address these issues,
which are consistent with the findings in this research, and finally outline experiments
that could be carried out to test them.

One of my central findings was that cluster analysis following application of the
100 Hz HFS induction paradigm yielded distinct STD and LTD clusters in all four G  E
groups (Fig 4.3). Generation of these two clusters was not unique to this induction
paradigm, since alternative induction paradigms, such as the 10 Hz and 30 Hz paradigms
reported in Appendix 2, also resulted in distinct STD and LTD clusters. Importantly,
field potential recordings sum the extracellular fields from a population of neurons so the
observation of STD or LTD indicates that the majority of neurons at the recording site in
each hemi-slice expressed one or the other of these distinct forms of long-term plasticity.
I considered that there could be regional differences in the potential to induce STD and
LTD stemming from a preponderance of cortical over thalamic inputs or the distribution
of D1R or D2R expressing MSNs and that these regional differences could account for
the observed clusters, but as I have already discussed there are inconsistencies with each
of these explanations when applied to the observed data. Another possibility is that the
distinct STD and LTD clusters may be due to a threshold effect in which a simultaneous
convergence of glutamatergic and dopaminergic inputs onto a population of MSNs is
necessary to produce sufficient endocannabinoid feedback to allow the transition from
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STD to LTD to occur. Given that glutamatergic input is a necessary precondition to
depolarize MSNs from the DOWN state to the UP state and that this is a necessary
requisite for PTD, which was consistently observed, it appears that sufficient
glutamatergic input exists in the majority of slices. However, Lovinger and colleagues,
using high-speed chronoamperometry measurements of dopamine release in striatal
slices, found that a one second 100 Hz paradigm produced highly variable dopamine
outputs of 42.8 ± 21.3 µM (Partridge et al., 2002). Thus I hypothesize that: the HFS
paradigm will induce a transition from STD to LTD when a sufficient amount of
dopamine release converges with the glutamate-driven depolarization of MSNs in order
generate endocannabinoid production that exceeds a critical threshold.
To test this hypothesis, I suggest performing the 100 Hz HFS paradigm in field
potential slice recordings on WT mice while simultaneously using chronoamperometry to
measure dopamine release. I predict that LTD induction will correlate with higher tissue
dopamine concentrations and STD with lower dopamine concentrations in a given slice.
If these preliminary findings prove to be consistent with my hypothesis, a follow-up
experiment would be to perform the LTD induction experiments in the presence of
various concentrations of a dopamine agonist to determine if a particular agonist level
leads exclusively to the production of LTD. These findings would be strong support for
the hypothesis of an endocannabinoid threshold as the basis of the STD to LTD
transition.

As I showed in Fig. 4.5, in the presence of a D2R antagonist, all G × E groups
exhibited only a single cluster that recovered to baseline within 40 minutes. However,
the HET/PNE group, but not the HET/Sac group, exhibited significantly less recovery to
baseline following HFS than the WT/Sac control group. Additionally, I showed in Fig.
4.3 that the HET/PNE showed a less robust LTD than the WT/Sac control group. This
indicates that in the G × E condition, the induction of LTD is impaired by a process
involving D2Rs. As was previously discussed, the nicotine-stimulated release of
dopamine is decreased in synaptosomes prepared from the striatum of adolescent rats
prenatally exposed to nicotine (Gold et al., 2009). Using an adenovirus carrying a creinducible channelrhodopsin gene targeted to cholinergic interneurons, Cragg and
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colleagues (Threlfell et al., 2012) were able to demonstrate that cholinergic interneurons
can directly activate dopamine release through nAChRs expressed on dopaminergic
terminals. Additionally, nAChR antagonists have been shown to block LTD induction
(Partridge et al., 2002) suggesting that prenatal nicotine may act on nAChRs to impact
the induction of LTD by altering dopamine release with compensatory alterations in D2R
affinity. Through epigenetic factors, the prenatal action of nicotine on nAChRs on
dopaminergic terminals could lead to persistent down-regulation of dopamine release
onto adult striatal MSNs. Thus I hypothesize that: prenatal nicotine exposure combines
with the HET genotype to account for the impairments found in LTD induction through a
reduction in nAChR stimulated dopamine release from nAChRs expressed on dopamine
terminals that synapse onto MSNs.
To test this hypothesis, I propose measuring nAChR-dependent dopamine release
in striatal homogenates in response to a nAChR agonist by measuring [3H]-dopamine in
the four G  E groups as has previously been described (Gold et al., 2009). Briefly,
striatal homogenates from each G × E group are incubated in [3H]-dopamine, and then
separate samples are perfused with different concentrations of nAChR agonists including
ACh as well as agonists specific for α4β2 and α6β2 type nAChR receptors, and then
dopamine release is measured in terms of scintillation counts. A follow-up nAChR
agonist stimulated 86Rb efflux assay could also be undertaken on the same set of tissue
samples to determine changes in agonist binding of the nAChR receptor for the four G ×
E conditions (Gold et al., 2009). I would expect reduced nAChR binding to be associated
with reduced nAChR agonist induced dopamine release. Additionally I propose to
perform the LTD induction paradigm in the presence of a nAChR agonist. I would expect
that, if nAChR activation facilitated dopamine release, then LTD induction would be
partially restored in the presence of the nAChR agonist in the HET/PNE group toward
that which was found with WT/Sac controls. The caveat of course being that the reduced
D2R affinity in the HET/PNE group might preclude full restoration of LTD. These
experiments would support the specific hypothesis that prenatal nicotine exposure alters
nAChR-dependent dopamine release in the adult striatum. Testing specific epigenetic
factors that might be involved would be an important extension of these findings.
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My single [35S]-GTPS binding assay, performed on WT/Sac controls over a
range of agonist levels (fig 4.10), produced a Hill coefficient of 0.314, which is indicative
of a negative cooperativity in the binding of dopamine to D2Rs. Negative cooperativity is
consistent with D2Rs making receptor-receptor interactions such as dimers or tetramers
that allow for steric interactions between agonist binding sites. In some models of D2R
activity, this form of negative cooperativity is thought to be a normal process in D2R
agonist activation (Seeman et al., 2006). Thus I hypothesize that: binding of dopamine to
striatal D2Rs is characterized by negative cooperativity, and G  E factors and
interactions can alter the degree of this negative cooperativity. This hypothesis explains
my observation that D2Rs in the HET/PNE group had reduced affinity to be a result of an
interaction of adjacent binding sites rather than a change of affinity of individual sites.
To test this hypothesis, I propose undertaking [35S]-GTPS binding assays on the
four G  E groups across a range of agonist levels to obtain more complete specific
binding data in order to generate Hill plots and associated Hill coefficients for the four G
 E groups. If a negative Hill coefficient is found in all four groups, it would be
consistent with this negative cooperatively model of reduced agonist binding of the
receptors as would be anticipated for a dimerized (or multireceptor complex). In
comparing the four G  E groups, I would expect a greater reduction in the Hill
coefficient in the HET/PNE group relative to controls, which would be consistent with
the reduction in affinity found in the HET/PNE group that I observed by Scatchard
analysis of the [3H]-quinpirole saturation binding assays (Table 4.2).
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Appendix 1- Saturation Isotherms and Scatchard Plots for [ H]Quinpirole D2R agonist saturation experiments in four G  E
experimental groups
A series of Bradford assays were performed on striatal brain homogenates (two
male and two female striata) for each sample in the four G  E experimental groups as
described in the methods section. Protein quantification of these samples is shown below
in Table A1.1.

Sample

WT/Sac

WT/PNE

HET/Sac

HET/PNE

#1

2.0675

1.8889

2.5437

1.8889

#2

1.6508

2.0080

1.5913

2.5437

#3

1.5318

1.8294

1.8294

1.7699

#4

1.7104

1.4127

1.7699

2.1865

#5

1.5318

1.7104

1.5913

2.1270

Mean

1.698

1.770

1.865

2.103

SEM

0.099

0.101

0.176

0.134

Table A1.1: Protein quantification of each sample in four G  E experimental
groups using Bradford assays measured in (µg protein /µl)
3

The [ H]-Quinpirole D2R agonist saturation binding experiments were carried out
as described in the Methods in which Scatchard analysis was used to determine the Kd
and Bmax values for the four G  E experimental groups as described in the Results. In
order to perform the Scatchard analysis, a series of saturation isotherms were developed
from the data. Specific binding was determined by subtracting the non-specific binding at
a particular agonist concentration in the presence of a D2 specific antagonist spiperone
(50 µM) from the total binding at a particular agonist concentration in triplicate.
Saturation isotherms were developed by converting specific binding scintillation counts
for specific agonist levels (total binding minus non-specific binding as described) as well
as total and non-specific binding from scintillation counts. Radioligand concentrations
were also converted from scintillation count measurements. The formulas used to
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calculate specific binding (total and non-specific also) and the radioligand concentrations
is shown below. These calculations use standard methods determining binding and ligand
concentrations from scintillation counts. I utilized the Perkin-Elmer technical resource
3

associated with the [ H]-Quinpirole to perform the calculations listed below
(http://www.perkinelmer.com/Resources/TechnicalResources/ApplicationSupportKnowle
dgebase/radiometric/calculations.xhtml).

Specific binding is calculated as:

(This equation was also used to convert total and non-specific binding from scintillation counts)

Where: Specific Binding (as well as total & non-specific binding) = converted
scintillation counts measured in fM/mg protein; RLC = radioligand concentration =
converted scintillation counts of ligand concentration measured in nM; SA = specific
3

activity of the [ H]-Quinpirole as measured by manufacturer (Perkin Elmer)= 41,900
Ci/M (Ci = curie = 2.2*1012 scintillation counts); Incubation volume = 300 µl = 0.0003 l;
mg protein in sample = values obtained for each sample from Bradford assay (Table
A1.1)
Next, Scatchard plots are made by plotting the ratio of specifically bound ligand
to free ligand as a function of the ligand concentration based upon the specific binding
and radioligand concentrations calculated as shown above.

Bound/Free = Specific Binding/RLC

The Scatchard plot allows a linear regression to be made for the data using the
Michaelis-Menten equation:
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Where: [B] = Bound ligand (specific binding as calculated above); [F] = Free ligand
(radioligand concentration as calculated above); Bmax = Estimated maximum binding of
ligand for receptor (fmol/mg protein); Kd = Dissociation constant, estimated ligand
concentration where binding of receptor is ½ of maximum value (nM)

Transforming this equation yields a linear equation:

Thus: Bmax = X intercept ([B]/[F] =0); Kd = -1/slope of the line
Linear regression was used to produce Scatchard plots based on the plots of the
ratio of bound/free ligand versus specific bound ligand fraction in order to obtain the Kd
and Bmax values for each sample in the four G  E experimental groups.

Sample

WT/Sac

WT/PNE

HET/Sac

HET/PNE

#1

4.947

3.956

5.841

6.166

#2

2.639

1.973

2.565

7.591

#3

3.589

5.371

4.251

5.775

#4

2.343

2.603

4.821

6.901

#5

3.092

2.836

5.331

9.205

Mean

3.322

3.348

4.562

7.128

SEM

0.458

0.599

0.565

0.606

Table A1.2: Kd values of each sample in the four G  E experimental groups using
Scatchard analysis measured in (nM).
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Sample

WT/Sac

WT/PNE

HET/Sac

HET/PNE

#1

163.6

150.8

161.1

114.2

#2

143.4

83.3

70.6

129.4

#3

105.1

159.1

120.9

85.2

#4

80.5

146.8

143.8

134.4

#5

95.7

100.0

142.7

134.1

Mean

117.7

128.0

127.8

119.5

SEM

15.5

15.2

15.7

9.3

Table A1.3: Bmax values of each sample in the four G  E experimental groups using
Scatchard analysis measured in (fmol/mg protein).

Below are presented plots of total, non-specific and specific binding as a function
3

of [ H]-Quinpirole concentration (left) and plots of the ratio of bound/free ligand versus
specific bound ligand fraction (right) for each sample in the four G  E experimental
groups consecutively, by which the Kd and Bmax values were calculated.
Since linear regression was used to produce the Scatchard plots based on the plots
of the ratio of bound/free ligand versus specific bound ligand fraction, the linear
regression R2 fitting parameters are listed below for each sample in the four G  E
experimental groups.

Sample

WT/Sac

WT/PNE

HET/Sac

HET/PNE

#1

0.53

0.51

0.74

0.66

#2

0.67

0.70

0.63

0.55

#3

0.60

0.70

0.54

0.63

#4

0.69

0.73

0.68

0.60

#5

0.61

0.58

0.52

0.68

Mean

0.62

0.64

0.62

0.62

SEM

0.06

0.10

0.09

0.05

Table A1.4: Linear regression fit R squared values of each sample in the four G  E
experimental groups.
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Appendix 2 – Alterations in STD and LTD occur with different
frequency paradigms and STD and LTD affects cortico-striatal
frequency filtering

Introduction
Synaptic plasticity underlies nervous system functions from signal processing to
learning and memory. Short-term changes occurring in presynaptic neurons and in
feedback circuits underlie the frequency dependency and instantaneous efficacy of
transmission of action potentials through neuronal networks. Long-term changes in both
the pre- and post-synaptic regions are thought to be the basis of learning and memory.
The glutamatergic synapse between Layer V cortical projection neurons and medium
spiny neurons in the dorsal striatum exhibits both of these forms of plasticity.
Importantly, the cortico-striatal circuit plays an important role in various forms of
associative learning and in modulation of motor behavior (Balleine et al., 2007).
The induction of long-term synaptic depression in the cortico-striatal synaptic
field is initiated by convergent glutamatergic (layer V) and dopaminergic (substantia
nigra) inputs onto medium spiny neurons (MSNs) leading to their depolarization and
activation of post-synaptic metabotropic glutamate receptors (mGluRs) and dopamine
type-2 receptors (D2Rs). Simultaneous depolarization of MSNs and activation of these
receptors leads to production of endocannabinoids by MSNs, which retrogradely bind
pre-synaptic CB1 receptors leading to long-term decreases in the probability of glutamate
release characterized as long-term depression (LTD) (Surmeier et al., 2007). The vast
majority of the investigations of LTD are based upon an induction paradigm using 3 to 4
trains of 100 Hz high frequency stimuli at maximum stimulus intensity along with
antagonists to probe the role of various receptors in the induction of LTD (Calabresi et
al., 1992). This induction through repetitive firing of glutamatergic fibers with coincident
dopaminergic input, produces an initial post tetanic depression (PTD) followed by a
process, which we have called short-term depression (STD), that lasts for about 10
minutes. In some instances, a longer lasting, LTD is induced, which is maintained for an
excess of 30 minutes (Lovinger et al., 1993).

102

We have previously investigated the role of D2 and CB1 receptors in the
induction of both LTD and STD following a 100 Hz high frequency stimulus paradigm
(Baca et al., 2013), which confirms the occurrence of both forms of plasticity in MSNs,
and the role of both receptors in the LTD induction process. However it is less well
known if the induction of STD and LTD depend upon the frequency and magnitude of the
induction stimulus. One of the few published studies, which examined how the induction
of LTD in the striatum may be influenced by induction frequency, used a 10 Hz 5 minute
HFS train as an induction paradigm (Ronesi and Lovinger, 2005) instead of a 100 Hz
frequency commonly employed. This form of LTD, unlike that induced with the 100 Hz
paradigm, does not seem to depend on post-synaptic depolarization or activation of
mGluRs. We therefore explored whether there are differences in the magnitude or
occurrence of STD and LTD as a result of the frequency and magnitude of the input
stimulus when delivered at frequencies between 10 Hz and 100 Hz.
In addition, GABAergic feedback mechanisms responsible for the low-pass filter
characteristics in MSNs in the striatum have been previously characterized (Jelinek and
Partridge, 2012). In this study, we have extended this research to probe the effect of HFS
induction of LTD or STD on these low-pass filter characteristics. This effort was funded
under LDRD Project Number 151347 and Title "A Comprehensive Approach to Decipher
Biological Computation to Achieve Next Generation High-performance Exascale
Computing".

Results
To characterize use-dependent plasticity in these slices, a set of distinct high
frequency stimulus (HFS) paradigms are used to elicit synaptic depression of cortical
inputs measured by extracellular field excitatory postsynaptic potential (fEPSP)
population spike (PS) amplitude recordings in the medial portion of the dorsal striatum in
coronal slices of P21 – P28 C57/Bl6 mice.
To characterize the role of the HFS paradigm on the induction of synaptic
depression, we used the following paradigms:


10 Hz; 5 minute train at half maximum or maximum stimulus intensity (3000
stimuli)
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10 Hz; 4 sets of trains separated by 1 minute at maximum stimulus intensity
(400 stimuli)



30 Hz; 4 sets of trains separated by 1 minute at maximum stimulus intensity
(400 stimuli)



100 Hz; 4 sets of trains separated by 1 minute half maximum or maximum
stimulus intensity (400 stimuli)

The paradigms that utilized four sets of trains were designed so that each would
include 400 stimuli, so each is referred to as a 400 stimuli HFS paradigm with a half
maximum or maximum input stimulus magnitude, except one of the 10 Hz paradigms
which had 3000 stimuli. Two 10 Hz paradigms were used, one with a 5 minute
continuous train of pulses (3000 stimuli) and another with 4 sets of trains of pulses (400
stimuli). The former was included in order to make comparisons with previous data
(Ronesi and Lovinger, 2005), which suggest that there may be different mechanisms
involved in the induction of LTD at this frequency. The latter 10 Hz, along with the 30 Hz
and 100 Hz HFS paradigms were included in order to assess the influence of the
frequency of a fixed number of stimulus pulses. We also included both half maximum
and maximum stimulus intensities during the HFS for some of the paradigms in order to
compare and contrast how the magnitude of the stimulus might affect the induction of
LTD.
In all of the HFS paradigms used, PSs exhibited an initial depression to ~20-30%
of baseline (post-tetanic depression, PTD). For some slices, the PS returned back to near
baseline levels within a few minutes, while for other slices it remained depressed for the
full 30 minute recording period (Fig. A2.1A). We used a cluster analysis (see
experimental procedures) to differentiate between two distinct populations, which were
operationally defined as short-term depression (STD) and long-term depression (LTD)
based on the percent of PS recovery after 30 minutes. Fig. A2.1B shows summary data of
the percent PS recovery following HFS for the 10 Hz 400 stimuli maximum input HFS
paradigm for the STD and LTD populations determined by cluster analysis as well as the
combined data from experiments with all HFS paradigms. Fig. A2.1C shows
representative PSs for the 10 minute baseline period and for the 30 minute period
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following HFS for slices that were assigned to STD and LTD populations by cluster
analysis. We found that each of the other HFS paradigm generated plasticity that could be
differentiated into distinct STD and LTD populations as was found with the 10 Hz HFS
paradigm shown in Fig A2.1.
We also performed a set of control experiments without HFS, to compare PSs at
30 minutes with PSs after an initial 10 minute baseline. In these control experiments, the
PS magnitudes did not vary significantly during the 40 minute recording period and were
found to be at ~95% of the baseline levels, at the end of the 40 minute period.
Additionally cluster analysis did not reveal significantly distinct populations in these
control data. The magnitude of PSs of control slices were used to compare changes in PS
recovery of the various HFS paradigms used in these experiments.
An initial comparison PS amplitudes following each of the HFS paradigms was
performed on the total population before cluster analyses were undertaken . A multiple
comparisons ANOVA (F6,118=7.17, p<0.0001) showed significant effects between the
different HFS paradigms examined (Fig. A2.2A). Interestingly, post-hoc analysis showed
that all of the HFS paradigms demonstrated a greater percent recovery of PS following
HFS than the 10 Hz 3000 stimuli maximum input HFS paradigm, which was also less
than the control population with no HFS applied (Fig A2.2A). None of the other
paradigms showed recovery of PS at 30 minutes after HFS that was distinct from the
control population. These results indicate that independent of cluster analysis, the 10 Hz
3000 stimuli maximum input HFS paradigm shows differences from other HFS
paradigms including others at 10 Hz.
We next assessed whether the induction of these two forms of synaptic plasticity
(LTD and STD) as determined by cluster analysis differed among the various HFS
paradigms examined. A multiple comparisons ANOVA (F6,53=28.53, p<0.0001) showed
significant effects between the LTD populations of the different HFS paradigms
examined (Fig. A2.2B). Post-hoc analysis of all of the LTD clusters showed significantly
less recovery to baseline of the PS amplitude 30 minutes after HFS compared to controls
(Fig. A2.2B). Additionally, post-hoc analysis showed that 4 HFS paradigms generated
LTD populations with significantly greater recovery to baseline than the 10 Hz 3000
stimuli maximum intensity HFS paradigm (Fig. A2.2B; note iii). A multiple comparisons
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ANOVA (F6,60=3.09, p<0.01) showed significant differences among the different HFS
paradigms in their ability to generate STD (Fig. A2.2C). However, post-hoc analysis did
not show significant differences between any of the HFS paradigms and controls.
We next compared the responses to HFS for the STD and LTD populations for the
10 Hz, 30 Hz and 100 Hz 4 × 400 stimuli maximum input HFS paradigms, since they
both included the same number of pulses and were delivered at maximum input. A
multiple comparisons ANOVA (F=29.20, p<0.0001) showed significant effects between
the LTD and STD populations with the different HFS paradigms (Fig. A2.3). Post-hoc
tests indicated that each HFS paradigm generated significant STD and LTD populations,
but there were no differences between STD or LTD populations for each of the HFS
paradigms (Fig. A2.3). However there were differences among the HFS paradigms in
their ability to elicit LTD. The 10 Hz 400 stimuli maximum intensity HFS paradigm
elicited LTD rather than STD in 56% of slices, versus 41% for the 30 Hz paradigm, and
31% for the 100 Hz paradigm.
It has been demonstrated recently that low-pass filter characteristics of corticostriatal circuits are dependent on GABAergic feedback, since use of a GABA inhibitor
depresses the high frequency roll off to random stimulus frequencies between 2 and 100
Hz (Jelinek and Partridge, 2012). We decided to test if these low pass filtering
characteristics of STD and LTD clusters change as a result of the HFS paradigm. We
chose the 10 Hz 400 stimuli maximum intensity HFS paradigm for these experiments,
since it was the most effective in eliciting LTD and it was a markedly different HFS
paradigm from that used in the previous study (Fig. A2.3). As in the previous study
(Jelinek and Partridge, 2012), a random stimulus paradigm was used in order to control
for the possibilities that the ascending or descending frequencies of fixed frequency
paradigms could affect the frequency dependence of the PS response.
Figure A2.4A shows the time course of PS responses for the STD and LTD
populations for the 10 Hz 400 maximum stimulus HFS paradigm used in the experiments
to test frequency responses before and after HFS. Figure A2.4A shows the sequence of:
an initial 10 minute set of baseline stimulus recordings made at half maximum intensity
(BL#1); then the first random stimulus paradigm (RS#1); then a second 10 minute set of
baseline recordings at half maximum intensity (BL#2); then four trains of 10Hz stimuli at
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maximum intensity (HFS; 400 stimuli total); then a 30 minute set of recordings
(RESULT); and finally the second random stimulus paradigm (RS#2) for the STD and
LTD populations as determined by cluster analysis.
As shown in Fig. A2.4C, there were STD and LTD cluster populations as
expected following the HFS paradigm. As shown in Fig. A2.4D, the ratio of the PS
amplitudes during BL#2 to that during BL#1 was close to unity for both the STD and
LTD populations, which indicates that there was not a significant depression in the PSs
due to the first random stimulus paradigm.
To determine the effect the induction of synaptic depression on the low pass filter
properties, the responses to RS#1 were compared with the responses to RS#2. Analysis
for RS#1 included both slices that received subsequent HFS and control slices that did
not, since RS#1 occurs prior the HFS protocol. Analysis for RS#2 was performed
separately on STD and LTD populations. Fig. A2.4B shows a log-log plot (Bode
magnitude plot) of the normalized amplitudes of PS responses to frequencies between 2
to 60 Hz. A least squares regression fit of RS#1 data to a 3rd order Butterworth low pass
filter yielded a corner frequency (CoF) of 4.37 Hz and a stop band slope parameter (A) of
0.0185. A similar fit of the RS#2 STD cluster yielded a CoF of 14.20 and an A of 0.0370,
indicating a prominent increase in the high frequency cut off frequency and slight shift in
the stop band slope compared to RS#1. A least squares regression fit for the RS#2 LTD
cluster yielded a CoF of 3.45 and an A of 0.0084, indicating a slight decrease in high
frequency cut off frequency and a more prominent shift in the stop band slope compared
to RS#1. We compared the frequency-dependent PS amplitudes for the RS#1 and RS#2
STD and LTD clusters at 20.8 Hz, 35.2 Hz and 57.5 Hz. As shown in Fig. A2.4E, at 20.8
Hz, no significant difference was found between RS#1 and RS#2 STD and LTD clusters.
At 35.2 Hz, the RS#2 STD and LTD PS amplitudes of the clusters were both significantly
greater than that of the RS#1 cluster. At 57.2 Hz, the RS#2 LTD the PS amplitude of the
cluster was significantly greater than that of either the RS#2 STD cluster or the RS#1
cluster.
A set of control experiments was carried out using the same experimental
paradigm as shown in Fig. A2.4A, but without imposition of the HFS paradigm. We
found no significant differences in the magnitude of PSs representing the BL#1, BL#2,
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and results after 30 minutes, (data not shown), indicating that there was no run down of
PS magnitudes over this time period. A least squares regression of these data to a 3rd
order Butterworth low pass filter gave a CoF of 5.15 Hz and a stop band slope parameter,
A, of 0.0190 for the RS#1 controls, and a CoF of 5.68 Hz and a stop band slope
parameter A of 0.0170 for the RS#2 controls. These values were comparable to those
found for RS#1 in those experiments in which HFS was applied.
We next repeated the 10 Hz 400 maximum stimuli experiments in the presence of
20µM picrotoxin, a GABAA receptor antagonist. As before, cluster analysis identified
distinct STD and LTD populations at the 30 minute time period following HFS. However
We could not obtain significant least squares fit of the data to a 3rd order Butterworth low
pass filter, in the RS#1, RS#2 STD, orRS#2 LTD cluster, indicating a major GABAAdependent component of the low pass filter characteristic previously shown (Jelinek and
Partridge, 2012), both during RS#1, but also following HFS (data not shown).

Discussion
Long-term synaptic plasticity is generally accepted as a model of learning and
memory. To be a valid model, this plasticity must be initiated by a physiologicallyrelevant neural signal. HFS stimuli that mimic theta activity are commonly used to
initiate LTP, but a similar association with the EEG power spectrum has not been made
for LTD induction.
In this study, the 10 Hz 400 stimuli maximum input HFS paradigm was found to
have a higher likelihood of producing LTD than the 30 Hz and 100 Hz 400 maximum
input stimuli paradigms (Fig. A2.3), though the resulting magnitudes for LTD and STD
were similar. The 10 Hz 3000 stimuli HFS was found to produce a more robust level of
LTD (less recovery after 30 minutes compared to baseline levels) compared to the 400
stimuli paradigms (Fig. A2.2). Thus, the 10 Hz HFS stimuli in the alpha range (8 – 13
Hz) was the most likely of those tested to produce LTD rather than STD and a longer
train of stimuli (3000 versus 400) produced a more robust level of LTD.
Not much is currently known about how firing rates of striatal MSNs can vary in
vivo. Intra-somatic current injection of between 100 – 400 pA into patch-clamped D1 or
D2 expressing MSN reveals a firing rate of ~0 - ~15 Hz for D1 MSNs and ~0 - ~25 Hz
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for D2 MSNs., This indicates that D2 MSNs are more excitable than D1 MSNs (Gertler
et al., 2008). D2Rs expressed in MSNs have been associated with striatal LTD so perhaps
frequencies between 5 - 25 Hz may be associated with striatal LTD in vivo. This is
consistent with my observation that LTD is more robust at lower frequency levels.
Two of the HFS paradigms compared the use of ½ maximum stimulus intensity to
maximum stimulus intensity during the HFS paradigm. No significant differences were
found between the 100 Hz 400 stimuli HFS paradigm at ½ maximum input versus the
same stimulus at maximum input (Fig. A2.2B). A more robust level of LTD was found for
the 100 Hz 3000 stimuli HFS stimuli at maximum stimulus intensity compared to the
same paradigm at ½ maximum stimulus, which was comparable to other stimulus
paradigms (Fig. A2.2B).
Using a random stimulus paradigm (Jelinek and Partridge, 2012) before and after
the 10 Hz 400 maximum input HFS paradigm we found that prior to the introduction of
HFS, the previously characterized low-pass filter characteristics were confirmed (Fig.
A2.4B; gray). Additionally we found the previously reported dependency of the low-pass
filter characteristics on GABAergic feedback, since use of a GABA inhibitor greatly
attenuated the low-pass filtering characteristics. Following the HFS stimulus, the STD
population showed a distinct shift in the low-pass filter as characterized by an increase in
the CoF from 4.4 Hz to 14.2 Hz (Fig. A2.4B; red). Interestingly, the CoF of the LTD
population did not change significantly from its baseline value of 3.44 Hz, but the
population did show a reduction in its stop band slop parameter A (Fig. A2.4B; green).
These results show that low-pass filter characteristics are differentially affected between
the STD and LTD populations. It would be interesting to determine whether this
difference reflects a difference in the cortico-striatal synapses that precedes the induction
of long-term plasticity or if it is more causally related to the induction paradigm. As was
true prior to the introduction of HFS, both STD and LTD populations were found to
depend on GABAergic feedback, since independent experiments performed in the
presence of a GABAAR antagonist revealed that STD and LTD low-pass filtering was
greatly attenuated or eliminated.
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Methods
Animals
All experiments were approved by the Institutional Animal Care and Use
Committee at the University of New Mexico Health Sciences Center Laboratory Animal
Care and Use Committees and the National Institutes of Health. Coronal striatal slices
were prepared from approximately 21 - 28 day old C57/Bl6 mice as previously described
(Schiess et al., 2006) and electrophysiological techniques were identical to those
described in the Methods.

HFS Paradigm
To assess long-term synaptic plasticity in the cortico-striatal field, a 10 minute
baseline was established at ½ maximum stimulus intensity, then one of 7 high frequency
stimulus (HFS) paradigms with stimulus pulses at either half maximum or maximum
intensity was applied, and finally 30 minutes of recordings were obtained again at ½
maximum stimulus intensity. The average amplitude of the final 10 PSs during the 30
minute period was compared to the average amplitude of 32 PSs during the 10 minute
pre-HFS baseline in order to determine the percentage of change relative to the baseline.
The six HFS paradigms consisted of the following: 4 sets of 10, 30, or 100 Hz pulses
(each train 100 pulses) at the half maximum or maximum stimulus intensity (except 30
Hz done only at maximum intensity) separated by 1 minute per set for 400 stimuli total;
or a continual 5 minute train of 10 Hz pulses at half maximum or maximum stimulus
intensity for 3000 stimuli total.

Electrophysiology Filtering Paradigm
The filter properties of the cortico-striatal field were determined by an additional
stimulus paradigm, which was applied before and after the assessment of long-term
synaptic plasticity. In this random frequency train paradigm, 5 Hz to 60 Hz instantaneous
frequency pulse trains were produced by a waveform stimulus file in Clampex
(Molecular Devices, Sunnyvale, CA
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Frequency response data for PSs were fit with a 3rd order Butterworth low pass
filter with a least squares regression using the Levenberg-Marquart method in ProStat (v
6, Poly Software International, Pearl River NY) using equations 1 and 2.

Vmean  A  log10 (1  fr 6 )(1)
Hz
fr 
(2)
CoF
where: Vmean is the frequency-dependent gain that was fit to the average PS amplitude
during the binned PS amplitudes generated by the random frequency protocol, Hz is the
stimulus frequency, CoF is the cutoff frequency for a low pass filter, and A is a scaling
factor that is directly proportional to the roll off of the filter.
To assess changes in frequency filtering during long-term synaptic plasticity in
the cortico-striatal field, (a) a 10 minute baseline was established at ½ maximum stimulus
intensity, (b) the first set of random stimulus pulse trains above was delivered, (c) the 10
Hz stimulus (HFS) paradigm above (400 pulses) with stimulus pulses at ½ maximum or
maximum intensity was applied, (d) 30 minutes of recordings were obtained again at ½
maximum stimulus intensity and (e) the second set of random stimulus pulse trains above
was delivered. The average amplitude of the final 10 population spikes during the 30
minute period was compared to the average amplitude of 32 population spikes during the
10 minute pre-HFS baseline in order to determine the percentage of change relative to the
baseline.

Drugs
Picrotoxin (Tocris, Ellisville, MO, USA) was stored frozen in aliquots and diluted
to the appropriate concentration in ACSF for electrophysiology on the day of the
experiment, or the appropriate concentrations as dictated by the pharmacological assays.

Statistical Analysis
SPSS 16.0 (SPSS, Inc., Chicago, IL) was used for statistical analysis of data.
Numerical values for data measurements are expressed as the mean ± standard error
unless otherwise specified. Statistical p values were represented as follows: * p < 0.05;
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** p < 0.01 and *** p<0.001. ANOVA analysis followed by a Tukey’s HSD post-hoc
test was carried out to compare different frequency paradigms. Cluster analysis was
performed as described in the Methods.
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Fig. A2.1: Cluster analysis determination of 10 Hz 400 stimuli maximum input HFS
paradigm. A Representative example of population spikes traces before (gray) and after
(colored) in 10 Hz 4x 1s maximum input HFS paradigm for STD cluster (> 70% recovery, n = 8,
red) and LTD cluster (<60% recovery, n = 10, blue). B Mean +/- SEM of individual LTD and
STD clusters and combined data for PS amplitudes shown in C. Cluster analysis assigns data
points to clusters such that individual SEMs will have minimal overlap with combined SEM. C
Time course of normalized population spike amplitudes separated into 2 groups determined by
cluster analysis of PS amplitudes 30 min after HFS.
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Fig. A2.2: Comparison of STD and LTD clusters in different HFS paradigms. A All
experiments no clustering. Percent recovery of population spike amplitudes before cluster
analysis following each of 6 HFS protocols. Note 1: 10 Hz 3000 stimuli HFS paradigm at
maximum (M) or half-maximum (1/2M) input stimulus. All other HFS paradigms were 4 trains
with a total of 400 stimuli. B Clusters with least recovery (LTD). Percent recovery of population
spike amplitude for clusters with the least recovery following each of 6 HFS protocols. Note iii:
These clusters were significantly different from the 10 Hz 3000 stimuli HFS paradigm as well as
controls. C Clusters with greatest recovery (STD). Percent recovery of population spike
amplitude for clusters with the greatest recovery following each of 6 HFS protocols. Statistics:
ANOVA multiple comparisons and Scheffe’s post hoc tests.
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responses at 20.8 Hz, 35.2 Hz and 57.5 Hz.
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